array(1) { [0]=> object(Apache_Solr_Document)#24 (3) { ["_documentBoost":protected]=> bool(false) ["_fields":protected]=> array(6) { ["content_id"]=> array(1) { [0]=> string(14) "DIRECTORY_4493" } ["content_title"]=> array(1) { [0]=> string(21) "MARIA ADELAIDE MARINI" } ["description"]=> array(1) { [0]=> string(134921) "

Curriculum Vitae Informazioni personali Nome/ Cognome Maria Adelaide Marini Fax 06 20902679 E-mail maride.marini@uniroma2.it Maride.marini@gmail.com Cittadinanza Italiana Data di nascita 14.01.1959 Stato Civile Coniugata con due figli   Lavoro o posizione ricoperti - Professore Associato Confermato, afferente alla Cattedra di Medicina Interna (MED09) del Dipartimento di Medicina dei Sistemi, presso la Facoltà di Medicina e Chirurgia dell’Università degli Studi di Roma Tor Vergata - Responsabile del “Progetto ad Alta Valenza Scientifica” “Diabete e Genere” nell’ambito dell’Area Funzionale Aggregata di Medicina Interna presso il Policlinico di Tor Vergata Università degli Studi di Roma Tor Vergata - Coordinatore del Corso di Laurea Specialistica “Scienze e tecniche delle Attività Motorie Preventive e Adattate” presso la Facoltà di Medicina e Chirurgia di Roma Tor Vergata dall’AA 2009/20010 - Direttore della Scuola di Specializzazione in Medicina delle Emergenze e Urgenze dall’AA 2016/17 Nome e indirizzo del datore di lavoro Università degli Studi di Roma Tor Vergata- Policlinico di Tor Vergata Via Monpellier 1 00133 Roma Temi di ricerca - Meccanismi molecolari dell’insulino-resistenza; - Patogenesi molecolare del diabete di tipo 2 e dell’obesità; - Genetica del Diabete di tipo 2; - Sindrome ipoglicemica autoimmune da anticorpi anti-recettore insulinico; - Regolazione della secrezione insulinica; -Valutazione del rischio cardiovascolare in soggetti affetti da prediabete; - Terapia insulinica con infusione continua.

Capacità e competenze personali Madrelingua Italiano Altra lingua Inglese- Francese Maria Adelaide Marini é autrice o coautrice di numerose pubblicazioni scientifiche nell’ambito della fisiopatologia medica pubblicate su riviste internazionali. H Index (Scopus) 23 I10Index (Google Scholar) 38 Impact factor totale 286,44 Media IF 4,64

  PUBBLICAZIONI ORIGINALI SU RIVISTE INTERNAZIONALI CON PEER REVIEW

1) Bertoli A., Caputo S., Marini M.A., Santini S.A., Ghirlanda G., Greco A.V. "Inhibition of basal insulin secretion induces insulin resistance in normal man: evidence for a tonic effect of insulin on carbohydrate metabolism". Horm. Res. 31: 238-243, 1989

2) Borboni P., Di Cola G., Sesti G., Marini M.A., Del Porto P., Gilardini Montani M., Lauro R., De Pirro R. "ß-endorphin receptors on cultured and freshly isolated lymphocytes from normal subjects". Biochem. Biophys. Res. Commun. 163: 642-648; 1989.

3) De Pirro R., Borboni P., Marini M.A., Montemurro A., Sesti G., Lauro R. "Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action." J. Endocrinol. Invest. 13: 951-968, 1990.

4) Sesti G., Marini M.A., Tullio A.N., Montemurro A., Borboni P., Fusco, Accili D, Lauro R. "Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients".Biochem. Biophys. Res. Commun. 181: 1419-1424, 1991.

5) Sesti G., Marini M.A., Montemurro A., Borboni P., Di Cola G., Bertoli A. Lauro R., De Pirro R. "Evidence that human and porcine insulin affect differently the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies". J. Endocrinol. Invest. 14: 913-918, 1991.

6) Sesti G., Marini M.A., Montemurro A., Borboni P., Condorelli L., Haring HU., Ullrich A., Goldfine D., De Pirro R., Lauro R. "Evidence that two naturally occurring human insulin receptor a-subunit variants are immunologically distinct".Diabetes 41: 6-11, 1992.

7) Sesti G., Marini M.A., Briata P., Tullio A.N., Montemurro A., Borboni P., De Pirro R., Gherzi R., Lauro R. "Androgens increase insulin receptor gene expression and insulin responsiveness in Hep-2 larynx carcinoma cells". Mol Cell Endocrinol 86: 111-118,1992

8) Sesti G., Tullio A.N., Marini M.A., Manera E., Borboni P., Accili D., Longhi R, Fusco A., Lauro R., Montemurro A."Role of the exon 11 of the insulin receptor gene on insulin binding identified by anti-peptide antibodies". Mol Cell Endocrinol 101:121-127, 1994

9) Sesti G., Tullio A.N., D'Alfonso R., Napolitano ML., Marini M.A., Borboni P., Longhi R., Albonici L., Fusco A., Aglianò A.M., Manzari V., Lauro R. "Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein".Acta Diabetologica 31: 59-65, 1994

10) Bertoli A.,Fusco A., Magnani A, Marini M.A., Di Daniele N., Gatti S. Lauro R. "Efficacy of low dose GnRH analogue (Buserelin) in the treatment of hirsutism" Exp.Clin.Endocrinol 103 (1995) 15-20

11) Sesti G., D'Alfonso R., Vargas Punti M.D., Tullio A.N., Liu Y.Y., Federici M., Borboni P., Marini M.A., Lauro R., Fusco A."Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured EBV-transformed lymphocytes from insulin-resistant subjects" Diabetologia 39: 289-297, 1996

12) Federici M., Porzio O., Zucaro L., Giovannone B., Borboni P., Marini M.A., Lauro D., Sesti G. “Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients” Mol. Cell. Endocrinol. 135, 41-47, 1997

13) Bertoli A., Magnaterra R., Borboni P., Marini M.A., Barini A., Fusco A., Bollea M.R. "Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity." Horm Res 49(1):17-21, 1998

14) D’Alfonso R., Marini M.A., Frittitta L., Sorge R., Frontoni S., Porzio O., Mariani L.M., Lauro D., Gambardella S., Trischitta V., Federici M., Lauro R., Sesti G. “Polymorphism of the Insulin Receptor Substrate-2 in Patients with Type 2 Diabetes” J.Clin.Endocrinol.Metab. 88 (1):317-322, 2003

15) Sesti G., Cardellini M., Marini M.A., Frontoni S., D’Adamo M., Del Guerra S., Lauro D., De Nocolais P., Sbraccia P., Del Prato S., Gambardella S., Federici M., Marchetti P., Lauro R. “A common Polymorphism in the promoter UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects” Diabetes. 2003 May; 52 (5): 1280-3

16) Marini M.A., Frontoni S., Mineo D. Bracaglia D. Cardellini M., De Nicolais P., Baroni A., D’Alfonso R., Perna M., Lauro D., Federici M., Gambardella S., Lauro R., Sesti G. “ The Arg 972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients” J.Clin.Endocrinol. Matab. 2003 Jul; 88 (7): 3368-71

17) Mariani L.M., Marini M.A., Veneziani A., Bertoli A., Lauro R. “Morbid obesità: evaluation of metabolic indexes after adjustable silicone gastric banding. Acta Diabetol. 2003 Oct; Suppl 1: S263-5

18) Sesti G., Marini M.A., Cardellini M., Sciacqua A., Frontoni S., Andreozzi F., Irace C., Lauro D., Gnasso A., Federici M., Perticone F., Lauro R. “ The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to solfonylurea in patients with type 2 diabetes” Diabetes Care 2004 June; 27 (6): 1394-8

19) D’Adamo M., Perego l., Cardellini M., Marini M.A.,Frontoni S., Andreozzi F., Sciacqua A., Lauro D., Sbraccia P., Federici M., Paganelli m., Pontiroli A.E., Lauro R., Perticone F., Folli.F., Sesti G. “the-866 A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistence and icreased risk of type 2 diabetes.” Diabetes 2004 Jul;53 (7):1905-10

20) Sesti G., Sciacqua A., Cardellini M., Marini M.A., Maio R., Vatrano M., Succurro E., Lauro R., Federici M., Perticone F. “Plasma concentration of IGF-1 is indipendently associated with insulin sensitività in subjects with different degrees of glucose tolerance” Diabetes Care 2005 Jan;28(1):120-5.

21) Cardellini M., Perego L., D’Adamo M., Marini M.A., Procopio C., Hribal M.L., Andreozzi F., Frontoni S., Giacomelli M., Paganelli M., Pontiroli A.E., Lauro R., Folli F., Sesti G. C-174G Polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care. 2005 Aug;28(8):2007-12

22) Rizza S, Tesauro M, Cardellini M, meneghini R, Bellia A, Marini MA, Lauro D, Sbraccia P, Sesti G, Lauro R, Federici M. Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):431-2.

23) Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, Marini MA, Tassi V, Lauro R, Perticone F, Sesti G. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. Diabetes. 2006 May;55(5):1529-33.

24) Andreozzi F, Laratta E, Cardellini M, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G. Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of italian-caucasian nondiabetic subjects. Diabetes. 2006 Jul;55(7):2021-4.

25) Cardellini M, Marini MA, Frontoni S, Hribal ML, Andreozzi F, Perticone F, Federici M, Lauro D, Sesti G. Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E347-52. Epub 2006 Sep 12.

26) Cardellini M, Andreozzi F, Laratta E, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G. Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. Diabetes Metab Res Rev. 2006 Sep 4

27) Cardellini M, Marini MA, Frontoni S, Hribal ML, Andreozzi F, Perticone F, Federici M, Lauro D, Sesti G. “Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients.” Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E347-52

28) Ludovico O, Pellegrini F, Di Paola R, Minenna A, Mastroianno S, Cardellini M, Marini MA, Andreozzi F, Vaccaro O, Sesti G, Trischitta V. “Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk.” Obesity (Silver Spring). 2007 May;15(5):1076-81.

29) Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F, Sesti G.“Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women.” Diabetes Care. 2007 Aug;30(8):2145-7. Epub 2007 May 16.

30) Sesti G, Andreozzi F, Bonadonna RC, De Mattia G, Leonetti F, Luzi L, Marini MA, Natali A, Vettor R, Bonora E; Group of Italian Scientists of Insulin Resistance (GISIR). “Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database.” Diabetes Metab Res Rev. 2008 Feb;24(2):130-6.

31) Staiger H, Stancáková A, Zilinskaite J, Vänttinen M, Hansen T, Marini MA, Hammarstedt A, Jansson PA, Sesti G, Smith U, Pedersen O, Laakso M, Stefan N, Fritsche A, Häring HU.“A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study.” Diabetes. 2008 Feb;57(2):514-7

32) Bonora E, Capaldo B, Perin PC, Del Prato S, De Mattia G, Frittitta L, Frontoni S, Leonetti F, Luzi L, Marchesini G, Marini MA, Natali A, Paolisso G, Piatti PM, Pujia A, Solini A, Vettor R, Bonadonna RC; on behalf of the Group of Italian Scientists of Insulin Resistance (GISIR).“Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database.” Nutr Metab Cardiovasc Dis. 2007 Nov 28

33) Succurro E, Marini MA, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F, Sesti G. “Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.” Obesity (Silver Spring). 2008 Aug;16(8):1881-6.

34) Presta I, Andreozzi F, Succurro E, Marini MA, Laratta E, Lauro R, Hribal ML, Perticone F, Sesti G. “IL-18 gene polymorphism and metabolic syndrome.” Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):e5-6. Epub 2009 Jan 26.

35) Succurro E, Marini MA, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Hribal ML, Lauro R, Perticone F, Sesti G. “Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels.” Diabetes Metab Res Rev. 2009 May;25(4):351-6.PMID: 19319930

36) Succurro E, Andreozzi F, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G. “Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects.” Nutr Metab Cardiovasc Dis. 2009 Apr 3

37) Succurro E, Marini MA, Arturi F, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G “Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis” Atherosclerosis. 2009 Apr 11.

38) Fiore AM, Marinoni GM, Piccione A, Marini MA, D'Adamo M, Lauro R, Sbraccia P. A rare cardiac finding in a morbidly obese patient with severe hypertension Intern Emerg Med. 2010 Oct 9.

39) Hribal ML, Presta I, Procopio T, Marini MA, Stančáková A, Kuusisto J, Andreozzi F, Hammarstedt A, Jansson PA, Grarup N, Hansen T, Walker M, Stefan N, Fritsche A, Häring HU, Pedersen O, Smith U, Laakso M, Sesti G; on behalf of the EUGENE2 Consortium.Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B Diabetologia. 2011 Jan 14.

40) Succurro E, Marini MA, Arturi F, Grembiale A, Fiorentino TV, Andreozzi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects. Am J Cardiol. 2011 Jun 1;107(11):1650-5. Epub 2011 Mar 21. 41) Morviducci L, Di Flaviani A, Lauria A, Pitocco D, Pozzilli P, Suraci C, Frontoni S; Cappa M, Patera IP, Manfrini S, Bracaglia D, Ciampittiello G, Cicconetti E, Ventura C, Bloise D, Tatti P, Leotta S, Visalli N, Caputo S, Ghirlanda G, Giaccari A, Gisella Cavallo M, Leonetti F, Lauro D, Mancabitti ML, Marini MA, Spallone V, Napoli A, Pugliese G, Nardone MR, Tubili C, Giuliano M, Fava D, Piergiovanni F, Forte E, Tuccinardi F, Chiaramonte F, Buzzetti R, Leto G. CSII Study Group Of Lazio Region, Italy Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit. Diabetes Technol Ther. 2011 Oct;13(10):1071-4. doi: 10.1089/dia.2011.0056. Epub 2011 Jun 29. 42) Marini MA, Succurro E, Arturi F, Ruffo MF, Andreozzi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G. Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians. Nutr Metab Cardiovasc Dis. 2012 Jul;22(7):561-6. Epub 2011 Sep 23. 43) Cardellini M, Menghini R, Luzi A, Davato F, Cardolini I, D'Alfonso R, Gentileschi P, Rizza S, Marini MA, Porzio O, Lauro D, Sbraccia P, Lauro R, Federici M Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness. Diabetes. 2011 Dec;60(12):3265-70. Epub 2011 Oct 7. 44) Castaldo E, Sabato D, Lauro D, Sesti G, Marini MA Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.PLoS One. 2011;6(12):e28312. Epub 2011 Dec 2. 45) Marini MA, Succurro E, Frontoni S, Mastroianni S, Arturi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G. Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels.Diabetes Care. 2012 Apr;35(4):868-72. Epub 2012 Feb 22. 46) Marini MA, Succurro E, Castaldo E, Cufone S, Arturi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G. Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria.Diabetes Care. 2012 May;35(5):1144-9. Epub 2012 Mar 7. 47) Sciacqua A, Marini MA, Hribal ML, Perticone F, Sesti G. Association of insulin resistance indexes to carotid intima-media thickness. PLoS One. 2013;8(1):e53968. doi: 10.1371/journal.pone.0053968. Epub 2013 Jan 9. 48) Marini MA, Frontoni S, Succurro E, Arturi F, Sciacqua A, Hribal ML, Perticone F, Sesti G. Insulin sensitivity, and β-cell function in relation to hemoglobin A1C. Nutr Metab Cardiovasc Dis. 2013 Apr 16. S0939-4753(13)00031-8. 49) Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Hribal ML, Perticone F, Sesti G Insulin clearance is associated with carotid artery intima-media thickness. Atherosclerosis. 2013 Aug;229(2):453-8. doi: 10.1016/j.atherosclerosis.2013.06.011. Epub 2013 Jun 22 50) Mannino GC, Greco A, De Lorenzo C, Andreozzi F, Marini MA, Perticone F, Sesti G. A fasting insulin-raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity. PLoS One. 2013 Dec 31;8(12). 51) Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Hribal ML, Perticone F, Sesti G. Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels. PLoS One. 2013 Oct 23;8(10):e77440. doi: 10.1371/journal.pone.0077440. eCollection 2013. 52) Sesti G, Mannino GC, De Lorenzo C, Greco A, Sciacqua A, Marini MA, Andreozzi F, Perticone F A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease.Atherosclerosis. 2013 Nov;231(1):141-4. doi: 10.1016/j.atherosclerosis.2013.08.041. Epub 2013 Sep 14. 53) Sesti G, Hribal ML, Procopio T, Fiorentino TV, Sciacqua A, Andreozzi F, Marini MA, Perticone F. Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects. Nutr Metab Cardiovasc Dis. 2014 Jul 18. pii: S0939-4753 54) Sesti G, Andreozzi F, Fiorentino TV, Mannino GC, Sciacqua A, Marini MA, Perticone F High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects.Acta Diabetol. 2014 Oct;51(5):705-13. doi: 10.1007/s00592-014-0576-0. Epub 2014 Mar 12. 55) Sesti G, Mannino GC, Andreozzi F, Greco A, Perticone M, Sciacqua A, Marini MA, Perticone F. A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. Atherosclerosis. 2014 Jan;232(1):25-30 56) Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Perticone F, Sesti G. Differences in insulin clearance between metabolically healthy and unhealthy obese subjects.Acta Diabetol. 2014 Apr;51(2):257-61. 57) Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A, Grassi G, Iafusco D, Rabbone I, Schiaffini R; Italian Study Group on Diffusion of CSII Continuous subcutaneous insulin infusion in Italy: third national survey. Diabetes Technol Ther. 2015 Feb;17(2):96-104. 58) Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, Sciacqua A, Hribal ML, Perticone F, Sesti G. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. J Clin Endocrinol Metab. 2015 59) Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, Sciacqua A, Hribal ML, Perticone F, Sesti G.Response to the Letter: Comment to the letter by Marathe CS, Rayne CK, Jones KL, Horowitz M.J Clin Endocrinol Metab. 2016 Feb;101(2):L35 60) Spiga R, Marini MA, Mancuso E, Di Fatta C, Fuoco A, Perticone F, Andreozzi F, Mannino GC, Sesti G. Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells. Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1241-1249. doi: 10.1161/ATVBAHA.117.309128. Epub 2017 Apr 13. PMID: 28408375 61) Marini MA, Mannino GC, Fiorentino TV, Andreozzi F, Perticone F, Sesti G. A polymorphism at IGF1 locus is associated with anemia. Oncotarget. 2017 May 16;8(20):32398-32406. doi: 10.18632/oncotarget.16132. PMID: 28415730 62) Marini MA, Fiorentino TV, Succurro E, Pedace E, Andreozzi F, Sciacqua A, Perticone F, Sesti G. Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS One. 2017 Apr 20;12(4):e0175547. doi: 10.1371/journal.pone.0175547. eCollection 2017. PMID: 28426788 63) Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Succurro E, Sciacqua A, Perticone F, Sesti G Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels. Nutr Metab Cardiovasc Dis. 2017 Jul;27(7):601-608. doi: 10.1016/j.numecd.2017.04.001. Epub 2017 Apr 21. PMID: 28511905 64) Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Perticone M, Sciacqua A, Perticone F, Sesti G. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity. Acta Diabetol. 2017 Aug;54(8):775-784. doi: 10.1007/s00592-017-1004-z. Epub 2017 Jun 2. PMID: 28577138 65) Fiorentino TV, Marini MA, Succurro E, Sciacqua A, Andreozzi F, Perticone F, Sesti G Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction. Oncotarget. 2017 Jun 19. doi: 10.18632/oncotarget.18572. [Epub ahead of print]

RASSEGNE E CAPITOLI DI LIBRI

1. Bertoli A., Caputo S., Marini M.A., "I recettori insulinici nell'uomo in: "Il Diabete mellito fisiopatologia e clinica." Greco A.V., Ghirlanda G. p 159 Verducci ed.

2. Sesti G. , Marini M.A. "Le sindromi da estrema insulino - resistenza". Metabolismo Oggi 7: 95-102, 1990.

3. Sesti G., Marini M.A.“Meccanismi molecolari dell'insulino-resistenza". Metabolismo Oggi 11: 105-115, 1994

4. Marini M.A., Sesti G. "Malattie della Tiroide" Su vol. Medicina Clinica, Ed. Grasso, Capitolo XVI: 627-668, 1996 ISBN: 8886459092

5. Marini M.A., Sesti G. "Malattie delle paratiroidi" Su vol. Medicina Clinica, Ed. Grasso, Capitolo XVII: 669-682, 1996 ISBN: 8886459092

6. Marini M, Lauro D, Lauro R (2007). Malattie internistiche di interesse sessuologico. In: Iannini E A, Lennzi A, Maggi M A. Sessuologia Medica. Trattato di psicosessuologia, medicina della sessualità e salute della coppia. p. 174-179, MILANO:Elsevier Masson, ISBN: 8821429113

 

 Curriculum Vitae

Personal Information Name / Surname Maria Adelaide Marini Fax +39 06 20902679 E-mail maride.marini@uniroma2.it Citizenship Italian Date of birth 01/14/1959 Marital Status Married with two children Education and training She obtained a baccalaureate classical in Rome in 1977 at the Institute "Santa Maria degli Angeli";

- In the academic year 1977/78 has won the competition for admission and enrolled at the Faculty of Medicine, Catholic University of the Sacred Heart;

- In the academic years 1980/81 - 1981/82 and 1982/83 was a student inside at the Division of Gastroenterology of the Department of Special Medical Pathology at the same University;

- Earned at the same University Degree in Medicine and Surgery Day 24.10.1983 with a score of 110/110 cum laude;

- In November 1983 he became qualified to practice as a Surgeon;

- In October 1986, he obtained a Postgraduate Diploma in Endocrinology with a score of 70/70 cum laude at the 'University of Rome "Tor Vergata";

- In the academic year 1988/89, after being successful in the competition for free exams and qualifications is appointed technical officer (VIII level) relating to the Chair of Endocrinology, Department of Internal Medicine of the University of Rome "Tor Vergata";

- In the academic year 2000/2001 after the winner of the competition based on qualifications and tests, was appointed researcher relating to the Chair of Internal Medicine, Department of Internal Medicine of the University of Rome "Tor Vergata";

- In the academic year 2006/2007 after becoming the suitability assessment for Associate Professor at the Faculty of Medicine, University of Milan, scientific-disciplinary sector Med / 09 has been called to serve as Associate Professor, relating to the Chair of Internal Medicine, Department of Internal Medicine, Faculty of Medicine, University of Rome Tor Vergata.

Occupation or position held Project Manager with a high scientific "Diabetes and Gender" in Functional Area Aggregate of Internal Medicine at the Policlinico Tor Vergata University of Rome Tor Vergata Name and address of employer University of Rome Tor Vergata Policlinico Tor Vergata Research topics - Molecular mechanisms of insulin resistance; - Molecular pathogenesis of type 2 diabetes and obesity; - Genetics of Type 2 Diabetes; - Syndrome hypoglycemic autoimmune antibodies from anti-insulin receptor; - Regulation of insulin secretion. Mother tongue Italian Others languages English French Maria Adelaide Marini is author or co-author of numerous scientific publications in the medical pathophysiology published in international journals. The results are reported in the scientific publications in full on the following journal with "peer review": ORIGINAL PUBLICATIONS IN INTERNATIONAL JOURNALS WITH PEER REVIEW

1) Sesti G., Marini M.A., Montemurro A., Di Daniele N., Bertoli A., Cordera, Andraghetti G., De Pirro R., Lauro R., Monaco F., Roche J. "Preparation of monoclonal anti-insulin receptor antibodies labelled by 125-I". C. R. Soc. Biol. 182, 167-176; 1988.

2) Bertoli A., Caputo S., Marini M.A., Santini S.A., Ghirlanda G., Greco A.V. "Inhibition of basal insulin secretion induces insulin resistance in normal man: evidence for a tonic effect of insulin on carbohydrate metabolism". Horm. Res. 31: 238-243, 1989

3) Borboni P., Di Cola G., Sesti G., Marini M.A., Del Porto P., Gilardini Montani M., Lauro R., De Pirro R. "ß-endorphin receptors on cultured and freshly isolated lymphocytes from normal subjects". Biochem. Biophys. Res. Commun. 163: 642-648; 1989.

4) De Pirro R., Borboni P., Marini M.A., Montemurro A., Sesti G., Lauro R. "Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action." J. Endocrinol. Invest. 13: 951-968, 1990.

5) Sesti G., Marini M.A., Tullio A.N., Montemurro A., Borboni P., Fusco, Accili D, Lauro R. "Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients".Biochem. Biophys. Res. Commun. 181: 1419-1424, 1991.

6) Sesti G., Marini M.A., Montemurro A., Borboni P., Di Cola G., Bertoli A. Lauro R., De Pirro R. "Evidence that human and porcine insulin affect differently the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies". J. Endocrinol. Invest. 14: 913-918, 1991.

7) Sesti G., Marini M.A., Montemurro A., Borboni P., Condorelli L., Haring HU., Ullrich A., Goldfine D., De Pirro R., Lauro R. "Evidence that two naturally occurring human insulin receptor a-subunit variants are immunologically distinct".Diabetes 41: 6-11, 1992.

8) Sesti G., Marini M.A., Briata P., Tullio A.N., Montemurro A., Borboni P., De Pirro R., Gherzi R., Lauro R. "Androgens increase insulin receptor gene expression and insulin responsiveness in Hep-2 larynx carcinoma cells". Mol Cell Endocrinol 86: 111-118,1992

9) Sesti G., Tullio A.N., Marini M.A., Manera E., Borboni P., Accili D., Longhi R, Fusco A., Lauro R., Montemurro A."Role of the exon 11 of the insulin receptor gene on insulin binding identified by anti-peptide antibodies". Mol Cell Endocrinol 101:121-127, 1994

10) Sesti G., Tullio A.N., D'Alfonso R., Napolitano ML., Marini M.A., Borboni P., Longhi R., Albonici L., Fusco A., Aglianò A.M., Manzari V., Lauro R. "Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein".Acta Diabetologica 31: 59-65, 1994

11) Bertoli A.,Fusco A., Magnani A, Marini M.A., Di Daniele N., Gatti S. Lauro R. "Efficacy of low dose GnRH analogue (Buserelin) in the treatment of hirsutism" Exp.Clin.Endocrinol 103 (1995) 15-20

12) Sesti G., D'Alfonso R., Vargas Punti M.D., Tullio A.N., Liu Y.Y., Federici M., Borboni P., Marini M.A., Lauro R., Fusco A."Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured EBV-transformed lymphocytes from insulin-resistant subjects" Diabetologia 39: 289-297, 1996

13) Federici M., Porzio O., Zucaro L., Giovannone B., Borboni P., Marini M.A., Lauro D., Sesti G. “Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients” Mol. Cell. Endocrinol. 135, 41-47, 1997

14) Bertoli A., Magnaterra R., Borboni P., Marini M.A., Barini A., Fusco A., Bollea M.R. "Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity." Horm Res 49(1):17-21, 1998

15) D’Alfonso R., Marini M.A., Frittitta L., Sorge R., Frontoni S., Porzio O., Mariani L.M., Lauro D., Gambardella S., Trischitta V., Federici M., Lauro R., Sesti G. “Polymorphism of the Insulin Receptor Substrate-2 in Patients with Type 2 Diabetes” J.Clin.Endocrinol.Metab. 88 (1):317-322, 2003

16) Sesti G., Cardellini M., Marini M.A., Frontoni S., D’Adamo M., Del Guerra S., Lauro D., De Nocolais P., Sbraccia P., Del Prato S., Gambardella S., Federici M., Marchetti P., Lauro R. “A common Polymorphism in the promoter UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects” Diabetes. 2003 May; 52 (5): 1280-3

17) Marini M.A., Frontoni S., Mineo D. Bracaglia D. Cardellini M., De Nicolais P., Baroni A., D’Alfonso R., Perna M., Lauro D., Federici M., Gambardella S., Lauro R., Sesti G. “ The Arg 972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients” J.Clin.Endocrinol. Matab. 2003 Jul; 88 (7): 3368-71

18) Mariani L.M., Marini M.A., Veneziani A., Bertoli A., Lauro R. “Morbid obesità: evaluation of metabolic indexes after adjustable silicone gastric banding. Acta Diabetol. 2003 Oct; Suppl 1: S263-5

19) Sesti G., Marini M.A., Cardellini M., Sciacqua A., Frontoni S., Andreozzi F., Irace C., Lauro D., Gnasso A., Federici M., Perticone F., Lauro R. “ The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to solfonylurea in patients with type 2 diabetes” Diabetes Care 2004 June; 27 (6): 1394-8

20) D’Adamo M., Perego l., Cardellini M., Marini M.A.,Frontoni S., Andreozzi F., Sciacqua A., Lauro D., Sbraccia P., Federici M., Paganelli m., Pontiroli A.E., Lauro R., Perticone F., Folli.F., Sesti G. “the-866 A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistence and icreased risk of type 2 diabetes.” Diabetes 2004 Jul;53 (7):1905-10

21) Sesti G., Sciacqua A., Cardellini M., Marini M.A., Maio R., Vatrano M., Succurro E., Lauro R., Federici M., Perticone F. “Plasma concentration of IGF-1 is indipendently associated with insulin sensitività in subjects with different degrees of glucose tolerance” Diabetes Care 2005 Jan;28(1):120-5.

22) Cardellini M., Perego L., D’Adamo M., Marini M.A., Procopio C., Hribal M.L., Andreozzi F., Frontoni S., Giacomelli M., Paganelli M., Pontiroli A.E., Lauro R., Folli F., Sesti G. C-174G Polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care. 2005 Aug;28(8):2007-12

23) Mariani M.L., Fusco A., Turriziani M., Veneziani A., Marini M.A., De Lorenzo A., Bertoli A. Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity. Horm Metab Res. 2005 Apr;37(4):242-5

24) Rizza S, Tesauro M, Cardellini M, meneghini R, Bellia A, Marini MA, Lauro D, Sbraccia P, Sesti G, Lauro R, Federici M. Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):431-2. 25) Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, Marini MA, Tassi V, Lauro R, Perticone F, Sesti G. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. Diabetes. 2006 May;55(5):1529-33. 26) Andreozzi F, Laratta E, Cardellini M, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G. Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of italian-caucasian nondiabetic subjects. Diabetes. 2006 Jul;55(7):2021-4. Cardellini M, Marini MA, Frontoni S, Hribal ML, Andreozzi F, Perticone F, Federici M, Lauro D, Sesti G. Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E347-52. Epub 2006 Sep 12.

28) Cardellini M, Andreozzi F, Laratta E, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G. Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. Diabetes Metab Res Rev. 2006 Sep 4

29) Cardellini M, Marini MA, Frontoni S, Hribal ML, Andreozzi F, Perticone F, Federici M, Lauro D, Sesti G. “Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients.” Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E347-52

30) Ludovico O, Pellegrini F, Di Paola R, Minenna A, Mastroianno S, Cardellini M, Marini MA, Andreozzi F, Vaccaro O, Sesti G, Trischitta V. “Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk.” Obesity (Silver Spring). 2007 May;15(5):1076-81.

31) Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F, Sesti G.“Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women.” Diabetes Care. 2007 Aug;30(8):2145-7. Epub 2007 May 16.

32) Sesti G, Andreozzi F, Bonadonna RC, De Mattia G, Leonetti F, Luzi L, Marini MA, Natali A, Vettor R, Bonora E; Group of Italian Scientists of Insulin Resistance (GISIR). “Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database.” Diabetes Metab Res Rev. 2008 Feb;24(2):130-6.

33) Staiger H, Stancáková A, Zilinskaite J, Vänttinen M, Hansen T, Marini MA, Hammarstedt A, Jansson PA, Sesti G, Smith U, Pedersen O, Laakso M, Stefan N, Fritsche A, Häring HU.“A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study.” Diabetes. 2008 Feb;57(2):514-7

34) Bonora E, Capaldo B, Perin PC, Del Prato S, De Mattia G, Frittitta L, Frontoni S, Leonetti F, Luzi L, Marchesini G, Marini MA, Natali A, Paolisso G, Piatti PM, Pujia A, Solini A, Vettor R, Bonadonna RC; on behalf of the Group of Italian Scientists of Insulin Resistance (GISIR).“Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database.” Nutr Metab Cardiovasc Dis. 2007 Nov 28

35) Succurro E, Marini MA, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F, Sesti G. “Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.” Obesity (Silver Spring). 2008 Aug;16(8):1881-6.

36) Presta I, Andreozzi F, Succurro E, Marini MA, Laratta E, Lauro R, Hribal ML, Perticone F, Sesti G. “IL-18 gene polymorphism and metabolic syndrome.” Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):e5-6. Epub 2009 Jan 26.

37) Succurro E, Marini MA, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Hribal ML, Lauro R, Perticone F, Sesti G. “Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels.” Diabetes Metab Res Rev. 2009 May;25(4):351-6.PMID: 19319930

38) Succurro E, Andreozzi F, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G. “Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects.” Nutr Metab Cardiovasc Dis. 2009 Apr 3

39) Succurro E, Marini MA, Arturi F, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G “Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis” Atherosclerosis. 2009 Apr 11.

40) Fiore AM, Marinoni GM, Piccione A, Marini MA, D'Adamo M, Lauro R, Sbraccia P. A rare cardiac finding in a morbidly obese patient with severe hypertension Intern Emerg Med. 2010 Oct 9. [Epub ahead of print]

41) Hribal ML, Presta I, Procopio T, Marini MA, Stan?áková A, Kuusisto J, Andreozzi F, Hammarstedt A, Jansson PA, Grarup N, Hansen T, Walker M, Stefan N, Fritsche A, Häring HU, Pedersen O, Smith U, Laakso M, Sesti G; on behalf of the EUGENE2 Consortium.Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B Diabetologia. 2011 Jan 14. [Epub ahead of print]

42) Succurro E, Marini MA, Arturi F, Grembiale A, Fiorentino TV, Andreozzi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects. Am J Cardiol. 2011 Jun 1;107(11):1650-5. Epub 2011 Mar 21.

43) Morviducci L, Di Flaviani A, Lauria A, Pitocco D, Pozzilli P, Suraci C, Frontoni S; Cappa M, Patera IP, Manfrini S, Bracaglia D, Ciampittiello G, Cicconetti E, Ventura C, Bloise D, Tatti P, Leotta S, Visalli N, Caputo S, Ghirlanda G, Giaccari A, Gisella Cavallo M, Leonetti F, Lauro D, Mancabitti ML, Marini MA, Spallone V, Napoli A, Pugliese G, Nardone MR, Tubili C, Giuliano M, Fava D, Piergiovanni F, Forte E, Tuccinardi F, Chiaramonte F, Buzzetti R, Leto G. CSII Study Group Of Lazio Region, Italy Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit. Diabetes Technol Ther. 2011 Oct;13(10):1071-4. doi: 10.1089/dia.2011.0056. Epub 2011 Jun 29.

44) Marini MA, Succurro E, Arturi F, Ruffo MF, Andreozzi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G. Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians. Nutr Metab Cardiovasc Dis. 2012 Jul;22(7):561-6. Epub 2011 Sep 23.

45) Cardellini M, Menghini R, Luzi A, Davato F, Cardolini I, D'Alfonso R, Gentileschi P, Rizza S, Marini MA, Porzio O, Lauro D, Sbraccia P, Lauro R, Federici M Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness. Diabetes. 2011 Dec;60(12):3265-70. Epub 2011 Oct 7.

46) Castaldo E, Sabato D, Lauro D, Sesti G, Marini MA Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance.PLoS One. 2011;6(12):e28312. Epub 2011 Dec 2.

47) Marini MA, Succurro E, Frontoni S, Mastroianni S, Arturi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G.Insulin sensitivity, ?-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels.Diabetes Care. 2012 Apr;35(4):868-72. Epub 2012 Feb 22.

48) Marini MA, Succurro E, Castaldo E, Cufone S, Arturi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G. Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria.Diabetes Care. 2012 May;35(5):1144-9. Epub 2012 Mar 7.

49) Sciacqua A, Marini MA, Hribal ML, Perticone F, Sesti G Association of insulin resistance indexes to carotid intima-media thickness. PLoS One. 2013;8(1):e53968. doi: 10.1371/journal.pone.0053968. Epub 2013 Jan 9

50) Marini MA, Frontoni S, Succurro E, Arturi F, Sciacqua A, Hribal ML, Perticone F, Sesti G. .Insulin sensitivity, and ?-cell function in relation to hemoglobin A1C. Nutr Metab Cardiovasc Dis. 2013 Apr 16

51) Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Hribal ML, Perticone F, Sesti G. Insulin clearance is associated with carotid artery intima-media thickness. Atherosclerosis. 2013 Aug;229(2):453-8. doi: 10.1016/j.Atherosclerosis.2013.06.011. Epub 2013 Jun 22.

52) Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Perticone F, Sesti G. Differences in insulin clearance between metabolically healthy and unhealthy obese subjects. Acta Diabetol. 2013 Aug 30

53) Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Hribal ML, Perticone F, Sesti G. Decreased Insulin Clearance in Individuals with Elevated 1-h Post-Load Plasma Glucose Levels. PLoS One. 2013 Oct 23;8(10):e77440

54) Sesti G, Mannino GC, De Lorenzo C, Greco A, Sciacqua A, Marini MA, Andreozzi F, Perticone F. A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease. Atherosclerosis. 2013 Nov;231(1):141-4. doi: 10.1016/j.Atherosclerosis.2013.08.041. Epub 2013 Sep 14.

55) Sesti G, Hribal ML, Procopio T, Fiorentino TV, Sciacqua A, Andreozzi F, Marini MA, Perticone F. Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects. Nutr Metab Cardiovasc Dis. 2014 Jul 18. pii: S0939-4753

56) Sesti G, Andreozzi F, Fiorentino TV, Mannino GC, Sciacqua A, Marini MA, Perticone F High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects.Acta Diabetol. 2014 Oct;51(5):705-13. doi: 10.1007/s00592-014-0576-0. Epub 2014 Mar 12.

57) Sesti G, Mannino GC, Andreozzi F, Greco A, Perticone M, Sciacqua A, Marini MA, Perticone F. A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. Atherosclerosis. 2014 Jan;232(1):25-30

58) Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Perticone F, Sesti G. Differences in insulin clearance between metabolically healthy and unhealthy obese subjects.Acta Diabetol. 2014 Apr;51(2):257-61.

59) Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A, Grassi G, Iafusco D, Rabbone I, Schiaffini R; Italian Study Group on Diffusion of CSII Continuous subcutaneous insulin infusion in Italy: third national survey. Diabetes Technol Ther. 2015 Feb;17(2):96-104.

60) Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, Sciacqua A, Hribal ML, Perticone F, Sesti G. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. J Clin Endocrinol Metab. 2015

61) Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, Sciacqua A, Hribal ML, Perticone F, Sesti G.Response to the Letter: Comment to the letter by Marathe CS, Rayne CK, Jones KL, Horowitz M.J Clin Endocrinol Metab. 2016 Feb;101(2):L35

62) Spiga R, Marini MA, Mancuso E, Di Fatta C, Fuoco A, Perticone F, Andreozzi F, Mannino GC, Sesti G. Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-?B Signaling Pathway in HepG2 Cells. Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1241-1249. doi: 10.1161/ATVBAHA.117.309128. Epub 2017 Apr 13. PMID: 28408375

63) Marini MA, Mannino GC, Fiorentino TV, Andreozzi F, Perticone F, Sesti G. A polymorphism at IGF1 locus is associated with anemia. Oncotarget. 2017 May 16;8(20):32398-32406. doi: 10.18632/oncotarget.16132. PMID: 28415730

64) Marini MA, Fiorentino TV, Succurro E, Pedace E, Andreozzi F, Sciacqua A, Perticone F, Sesti G. Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS One. 2017 Apr 20;12(4):e0175547. doi: 10.1371/journal.pone.0175547. eCollection 2017. PMID: 28426788 65) Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Succurro E, Sciacqua A, Perticone F, Sesti G Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels. Nutr Metab Cardiovasc Dis. 2017 Jul;27(7):601-608. doi: 10.1016/j.numecd.2017.04.001. Epub 2017 Apr 21. PMID: 28511905

66) Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Perticone M, Sciacqua A, Perticone F, Sesti G. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity. Acta Diabetol. 2017 Aug;54(8):775-784. doi: 10.1007/s00592-017-1004-z. Epub 2017 Jun 2. PMID: 28577138

67) Fiorentino TV, Marini MA, Succurro E, Sciacqua A, Andreozzi F, Perticone F, Sesti G Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction. Oncotarget. 2017 Jun 19. doi: 10.18632/oncotarget.18572. [Epub ahead of print]

 

 

REVIEW AND BOOK CHAPTERS 1. Bertoli A., Caputo S., Marini M.A., "I, recettori insulinici nell'uomo in: "Il Diabete mellito fisiopatologia e clinica." Greco A.V., Ghirlanda G. p 159 Verducci ed.

2. Sesti G. , Marini M.A. "Le sindromi da estrema insulino - resistenza". Metabolismo Oggi 7: 95-102, 1990.

3. Sesti G., Marini M.A.“Meccanismi molecolari dell'insulino-resistenza". Metabolismo Oggi 11: 105-115, 1994

4. Marini M.A., Sesti G. "Malattie della Tiroide" Su vol. Medicina Clinica, Ed. Grasso, Capitolo XVI: 627-668, 1996

5. Marini M.A., Sesti G. "Malattie delle paratiroidi" Su vol. Medicina Clinica, Ed. Grasso, Capitolo XVII: 669-682, 1996

6. Marini M, Lauro D, Lauro R (2007). Malattie internistiche di interesse sessuologico. In: Iannini E A, Lennzi A, Maggi M A. Sessuologia Medica. Trattato di psicosessuologia, medicina della sessualità e salute della coppia. p. 174-179, MILANO:Elsevier Masson, ISBN: 8821429113

 

 

a:89:{i:0;a:14:{s:9:"citazione";s:271:"Fiorentino, T., Succurro, E., Marini, M., Pedace, E., Andreozzi, F., Perticone, M., et al. (2020). HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: a longitudinal study. DIABETES/METABOLISM RESEARCH AND REVIEWS, 36(4).";s:4:"data";s:7:"2020-02";s:2:"id";s:20:"PUBBLICAZIONE_420322";s:6:"handle";s:11:"2108/274777";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/09";s:9:"metadata4";N;s:9:"metadata5";s:122:"HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: a longitudinal study";s:9:"metadata6";s:113:"Fiorentino, T; Succurro, E; Marini, M; Pedace, E; Andreozzi, F; Perticone, M; Sciacqua, A; Perticone, F; Sesti, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:1;a:14:{s:9:"citazione";s:410:"Fiorentino T., V., Succurro, E., Marini, M.A., Pedace, E., Andreozzi, F., Perticone, M., et al. (2020). Experimental evidence indicates that high‐density lipoprotein (HDL) may stimulate glucose uptake and improve β‐cell function. The aim of this study was to evaluate whether lower levels of HDL may affect the risk to develop type 2 diabetes. DIABETES/METABOLISM RESEARCH AND REVIEWS [10.1002/dmrr.3289].";s:4:"data";s:7:"2020-01";s:2:"id";s:20:"PUBBLICAZIONE_388152";s:6:"handle";s:11:"2108/246067";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/09";s:9:"metadata4";N;s:9:"metadata5";s:244:"Experimental evidence indicates that high‐density lipoprotein (HDL) may stimulate glucose uptake and improve β‐cell function. The aim of this study was to evaluate whether lower levels of HDL may affect the risk to develop type 2 diabetes.";s:9:"metadata6";s:117:"Fiorentino T., V; Succurro, E; Marini, MA; Pedace, E; Andreozzi, F; Perticone, M; Sciacqua, A; Perticone, F; Sesti, G";s:9:"metadata7";s:17:"10.1002/dmrr.3289";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:2;a:14:{s:9:"citazione";s:274:"Fiorentino, T., Marini, M., Succurro, E., Andreozzi, F., & Sesti, G. (2019). Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage. BMJ OPEN DIABETES RESEARCH AND CARE.";s:4:"data";s:7:"2019-11";s:2:"id";s:20:"PUBBLICAZIONE_420318";s:6:"handle";s:11:"2108/274773";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/09";s:9:"metadata4";N;s:9:"metadata5";s:160:"Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage.";s:9:"metadata6";s:61:"Fiorentino, T; Marini, M; Succurro, E; Andreozzi, F; Sesti, G";s:9:"metadata7";s:26:"10.1136/bmjdrc-2019-000911";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:3;a:14:{s:9:"citazione";s:284:"Fiorentino, T., Marini, M., Succurro, E., Andreozzi, F., Perticone, M., Hribal, M., et al. (2019). Response to Letter to the Editor: "One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes". THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM.";s:4:"data";s:7:"2019-03";s:2:"id";s:20:"PUBBLICAZIONE_420320";s:6:"handle";s:11:"2108/274775";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/09";s:9:"metadata4";N;s:9:"metadata5";s:130:"Response to Letter to the Editor: "One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes"";s:9:"metadata6";s:113:"Fiorentino, T; Marini, M; Succurro, E; Andreozzi, F; Perticone, M; Hribal, M; Sciacqua, A; Perticone, F; Sesti, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:4;a:14:{s:9:"citazione";s:319:"Lepore, G., Bonfanti, R., Bozzetto, L., Di Blasi, V., Girelli, A., Grassi, G., et al. (2018). Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 28(4), 335-342 [10.1016/j.numecd.2017.12.001].";s:4:"data";s:7:"2018-04";s:2:"id";s:20:"PUBBLICAZIONE_333981";s:6:"handle";s:11:"2108/200740";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:118:"Acute and chronic complications; Continuous subcutaneous insulin infusion (CSII); Diabetes mellitus; Metabolic control";s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";s:239:"The objective of this cross-sectional study was to evaluate the degree of glycaemic control and the frequency of diabetic complications in Italian people with diabetes who were treated with continuous subcutaneous insulin infusion (CSII).";s:9:"metadata5";s:121:"Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion";s:9:"metadata6";s:2885:"Lepore, G; Bonfanti, R; Bozzetto, L; Di Blasi, V; Girelli, A; Grassi, G; Iafusco, D; Laviola, L; Rabbone, I; Schiaffini, R; Bruttomesso, D; Mammi, F; Bruzzese, M; Schettino, M; Nuzzo, Mg; Di Blasi, V; Fresa, R; Lambiase, C; Iafusco, D; Zanfardino, A; Confetto, S; Bozzetto, L; Annuzzi, G; Alderisio, A; Riccardi, G; Gentile, S; Marino, G; Guarino, G; Zucchini, S; Maltoni, G; Suprani, T; Graziani, V; Nizzoli, M; Acquati, S; Cavani, R; Romano, S; Michelini, M; Manicardi, E; Bonadonna, R; Dei Cas, A; Dall'Aglio, E; Papi, M; Riboni, S; Manicardi, V; Pugni, V; Lasagni, A; Street, Me; Pagliani, U; Rossi, C; Assaloni, R; Brunato, B; Tortul, C; Zanette, G; Li Volsi, P; Zanatta, M; Tonutti, L; Agus, S; Pellegrini, Ma; Ceccano, P; Pozzilli, G; Anguissola, B; Buzzetti, R; Moretti C, C; Leto, G; Pozzilli, P; Manfrini, S; Maurizi, Ar; Leotta, S; Altomare, M; Abbruzzese, S; Carletti, S; Suraci, C; Filetti, S; Manca Bitti, Ml; Arcano, S; Cavallo, Mg; De Bernardinis, M; Pitocco, D; Caputo, S; Rizzi, A; Manto, A; Schiaffini, R; Cappa, M; Benevento, D; Frontoni, S; Malandrucco, I; Morano, S; Filardi, T; Lauro, D; Marini, Ma; Castaldo, E; Sabato, D; Tuccinardi, F; Forte, E; Viterbori, P; Arnaldi, C; Minuto, N; D'Annunzio, G; Corsi, A; Rota, R; Scaranna, C; Trevisan, R; Valentini, U; Girelli, A; Bonfadini, S; Zarra, E; Plebani, A; Prandi, E; Felappi, B; Rocca, A; Meneghini, E; Galli, P; Ruggeri, P; Carrai, E; Fugazza, L; Baggi, V; Conti, D; Bosi, E; Laurenzi, A; Caretto, A; Molinari, C; Orsi, E; Grancini, V; Resi, V; Bonfanti, R; Favalli, V; Bonura, C; Rigamonti, A; Bonomo, M; Bertuzzi, F; Pintaudi, B; Disoteo, O; Perseghin, G; Perra, S; Chiovato, L; De Cata, P; Zerbini, F; Lovati, E; Laneri, M; Guerraggio, L; Bossi, Ac; De Mori, V; Galetta, M; Meloncelli, I; Aiello A, A; Di Vincenzo, S; Nuzzi, A; Fraticelli, E; Ansaldi, E; Battezzati, M; Lombardi, M; Balbo, M; Lera, R; Secco, A; De Donno, V; Cadario, F; Savastio, S; Ponzani, C; Aimaretti, G; Rabbone, I; Ignaccolo, G; Tinti, D; Cerutti, F; Bari, F; Giorgino, F; Piccinno, E; Zecchino, O; Cignarelli, M; Lamacchia, O; Picca, G; De Cosmo, S; Rauseo, A; Tomaselli, L; Tumminia, A; Egiziano, C; Scarpitta, Am; Maggio, F; Cardella, F; Roppolo, R; Provenzano, V; Fleres, M; Scorsone, A; Scatena, A; Gregori, G; Lucchesi, S; Gadducci, F; Di Cianni, S; Pancani, S; Del Prato, S; Aragona, M; Crisci, I; Calianno, A; Fattor, B; Crazzolara, D; Reinstadler, P; Longhi, S; Incelli, G; Rauch, S; Romanelli, T; Orrasch, M; Cauvin, V; Franceschi, R; Lalli, C; Pianta, A; Marangoni, A; Arico, Cn; Marin, N; Nogara, N; Simioni, N; Filippi, A; Gidoni Guarneri, Gl; Contin, Mlml; Decata, Ap; Bondesan, L; Confortin, L; Coracina, A; Lombardi, S; Costa Padova, S; Cipponeri, E; Scotton, R; Galasso, S; Boscari, F; Zanon, Ms; Vinci, C; Lisato, G; Gottardo, L; Bonora, E; Trombetta, M; Negri, C; Brangani, C; Maffeis, C; Sabbion, A; Marigliano, M";s:9:"metadata7";s:28:"10.1016/j.numecd.2017.12.001";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:5;a:14:{s:9:"citazione";s:297:"Fiorentino, T.v., Marini, M.a., Succurro, E., Andreozzi, F., Perticone, M., Hribal, M.l., et al. (2018). One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 103(9), 3131-3143 [10.1210/jc.2018-00468].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_346915";s:6:"handle";s:11:"2108/211555";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:94:"One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes";s:9:"metadata6";s:116:"Fiorentino, Tv; Marini, Ma; Succurro, E; Andreozzi, F; Perticone, M; Hribal, Ml; Sciacqua, A; Perticone, F; Sesti, G";s:9:"metadata7";s:21:"10.1210/jc.2018-00468";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:6;a:14:{s:9:"citazione";s:232:"Mannino, G.c., Fuoco, A., Marini, M.a., Spiga, R., Di Fatta, C., Mancuso, E., et al. (2018). The polymorphism rs35767 at IGF1 locus is associated with serum urate levels. SCIENTIFIC REPORTS, 8(1), 12255 [10.1038/s41598-018-29665-3].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_346917";s:6:"handle";s:11:"2108/211556";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:76:"The polymorphism rs35767 at IGF1 locus is associated with serum urate levels";s:9:"metadata6";s:106:"Mannino, Gc; Fuoco, A; Marini, Ma; Spiga, R; Di Fatta, C; Mancuso, E; Perticone, F; Andreozzi, F; Sesti, G";s:9:"metadata7";s:26:"10.1038/s41598-018-29665-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:7;a:14:{s:9:"citazione";s:273:"Fiorentino, T., Marini, M.a., Succurro, E., Sciacqua, A., Andreozzi, F., Perticone, F., et al. (2017). Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction. ONCOTARGET, 8(45), 79576-79586 [10.18632/oncotarget.18572].";s:4:"data";s:10:"2017-06-19";s:2:"id";s:20:"PUBBLICAZIONE_317378";s:6:"handle";s:11:"2108/186170";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:109:"Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction";s:9:"metadata6";s:89:"Fiorentino, T; Marini, Ma; Succurro, E; Sciacqua, A; Andreozzi, F; Perticone, F; Sesti, G";s:9:"metadata7";s:25:"10.18632/oncotarget.18572";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:8;a:14:{s:9:"citazione";s:192:"Marini, M.A., Mannino, G.c., Fiorentino, T.v., Andreozzi, F., Perticone, F., & Sesti, G. (2017). A polymorphism at IGF1 locus is associated with anemia. ONCOTARGET [10.18632/oncotarget.16132].";s:4:"data";s:10:"2017-03-11";s:2:"id";s:20:"PUBBLICAZIONE_310956";s:6:"handle";s:11:"2108/180288";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:54:"A polymorphism at IGF1 locus is associated with anemia";s:9:"metadata6";s:77:"Marini, MA; Mannino, Gc; Fiorentino, Tv; Andreozzi, F; Perticone, F; Sesti, G";s:9:"metadata7";s:25:"10.18632/oncotarget.16132";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:9;a:14:{s:9:"citazione";s:286:"Fiorentino, T.v., Marini, M.a., Succurro, E., Andreozzi, F., Sciacqua, A., Hribal, M.l., et al. (2017). Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. DIABETES RESEARCH AND CLINICAL PRACTICE, 134, 53-61 [10.1016/j.diabres.2017.09.017].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_323365";s:6:"handle";s:11:"2108/191670";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:112:"Hemoglobin glycation index; Hepatic steatosis; Non-enzymatic protein glycation; Nonalcoholic fatty liver disease";s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:96:"Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals";s:9:"metadata6";s:102:"Fiorentino, Tv; Marini, Ma; Succurro, E; Andreozzi, F; Sciacqua, A; Hribal, Ml; Perticone, F; Sesti, G";s:9:"metadata7";s:29:"10.1016/j.diabres.2017.09.017";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:10;a:14:{s:9:"citazione";s:330:"Marini, M.a., Fiorentino, T., Andreozzi, F., Mannino, G., Perticone, M., Sciacqua, A., et al. (2017). Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity. ACTA DIABETOLOGICA, 54(8), 775-784 [10.1007/s00592-017-1004-z].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_317381";s:6:"handle";s:11:"2108/186173";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:163:"Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity";s:9:"metadata6";s:102:"Marini, Ma; Fiorentino, T; Andreozzi, F; Mannino, G; Perticone, M; Sciacqua, A; Perticone, F; Sesti, G";s:9:"metadata7";s:25:"10.1007/s00592-017-1004-z";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:11;a:14:{s:9:"citazione";s:295:"Marini, M.a., Fiorentino, T., Andreozzi, F., Mannino, G., Succurro, E., Sciacqua, A., et al. (2017). Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 27(7), 601-608 [10.1016/j.numecd.2017.04.001].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_317389";s:6:"handle";s:11:"2108/186180";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:90:"Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels";s:9:"metadata6";s:101:"Marini, Ma; Fiorentino, T; Andreozzi, F; Mannino, G; Succurro, E; Sciacqua, A; Perticone, F; Sesti, G";s:9:"metadata7";s:28:"10.1016/j.numecd.2017.04.001";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:12;a:14:{s:9:"citazione";s:287:"Marini, M.a., Fiorentino, T.v., Succurro, E., Pedace, E., Andreozzi, F., Sciacqua, A., et al. (2017). Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLOS ONE, 12(4), e0175547 [10.1371/journal.pone.0175547].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_310952";s:6:"handle";s:11:"2108/180286";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:126:"Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals";s:9:"metadata6";s:101:"Marini, Ma; Fiorentino, Tv; Succurro, E; Pedace, E; Andreozzi, F; Sciacqua, A; Perticone, F; Sesti, G";s:9:"metadata7";s:28:"10.1371/journal.pone.0175547";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:13;a:14:{s:9:"citazione";s:331:"Spiga, R., Marini, M.a., Mancuso, E., Di Fatta, C., Fuoco, A., Perticone, F., et al. (2017). Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, ATVBAHA.117.309128 [10.1161/ATVBAHA.117.309128].";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_310958";s:6:"handle";s:11:"2108/180290";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:136:"Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells";s:9:"metadata6";s:106:"Spiga, R; Marini, Ma; Mancuso, E; Di Fatta, C; Fuoco, A; Perticone, F; Andreozzi, F; Mannino, Gc; Sesti, G";s:9:"metadata7";s:26:"10.1161/ATVBAHA.117.309128";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:14;a:14:{s:9:"citazione";s:289:"Fiorentino, T.v., Marini, M.A., Andreozzi, F., Arturi, F., Succurro, E., Perticone, M., et al. (2016). Response to the Letter: Comment to the letter by Marathe CS, Rayne CK, Jones KL, Horowitz M. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 101(2), L35-L35 [10.1210/jc.2015-4298].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_290020";s:6:"handle";s:11:"2108/162211";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:91:"Response to the Letter: Comment to the letter by Marathe CS, Rayne CK, Jones KL, Horowitz M";s:9:"metadata6";s:127:"Fiorentino, Tv; Marini, MA; Andreozzi, F; Arturi, F; Succurro, E; Perticone, M; Sciacqua, A; Hribal, Ml; Perticone, F; Sesti, G";s:9:"metadata7";s:20:"10.1210/jc.2015-4298";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:15;a:14:{s:9:"citazione";s:275:"Maurizi, A., Suraci, C., Pitocco, D., Schiaffini, R., Tubili, C., Morviducci, L., et al. (2016). Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience. JOURNAL OF DIABETES, 8(1), 41-44 [10.1111/1753-0407.12321].";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_283686";s:6:"handle";s:11:"2108/157235";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:117:"Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience";s:9:"metadata6";s:527:"Maurizi, A; Suraci, C; Pitocco, D; Schiaffini, R; Tubili, C; Morviducci, L; Giordano, R; Manfrini, S; Lauro, D; Frontoni, S; Pozzilli, P; Buzzetti, R; Bracaglia, D; Bloise, D; Cappa, M; Caputo, S; Cavallo, M; Chiaramonte, F; Ciampittiello, G; Cicconetti, E; Di Flaviani, A; Fava, D; Forte, E; Ghirlanda, G; Giaccari, A; Giuliano, M; Lauria Pantano, A; Leonetti, F; Leotta, S; Mancabitti, M; Marini, MA; Napoli, A; Nardone, M; Patera, I; Piergiovanni, F; Pugliese, G; Spallone, V; Tatti, P; Tuccinardi, F; Ventura, C; Visalli, N";s:9:"metadata7";s:23:"10.1111/1753-0407.12321";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:16;a:14:{s:9:"citazione";s:301:"Fiorentino, T., Marini, M., Andreozzi, F., Arturi, F., Succurro, E., Perticone, M., et al. (2015). One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 100(10), 3744-3751 [10.1210/jc.2015-2573].";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_273981";s:6:"handle";s:11:"2108/150967";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:316:"Adult; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fasting; Female; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin Resistance; Male; Middle Aged; Endocrinology, Diabetes and Metabolism; Biochemistry; Endocrinology; Clinical Biochemistry; Biochemistry (medical)";s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:104:"One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose";s:9:"metadata6";s:124:"Fiorentino, T; Marini, M; Andreozzi, F; Arturi, F; Succurro, E; Perticone, M; Sciacqua, A; Hribal, M; Perticone, F; Sesti, G";s:9:"metadata7";s:20:"10.1210/jc.2015-2573";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:17;a:14:{s:9:"citazione";s:253:"Marini, M., Frontoni, S., Succurro, E., Arturi, F., Fiorentino, T., Sciacqua, A., et al. (2014). Differences in insulin clearance between metabolically healthy and unhealthy obese subjects. ACTA DIABETOLOGICA, 51(2), 257-261 [10.1007/s00592-013-0511-9].";s:4:"data";s:7:"2014-04";s:2:"id";s:20:"PUBBLICAZIONE_184513";s:6:"handle";s:10:"2108/89701";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:91:"Differences in insulin clearance between metabolically healthy and unhealthy obese subjects";s:9:"metadata6";s:98:"Marini, M; Frontoni, S; Succurro, E; Arturi, F; Fiorentino, T; Sciacqua, A; Perticone, F; Sesti, G";s:9:"metadata7";s:25:"10.1007/s00592-013-0511-9";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:18;a:14:{s:9:"citazione";s:285:"Sesti, G., Andreozzi, F., Fiorentino, T., Mannino, G., Sciacqua, A., Marini, M., et al. (2014). High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. ACTA DIABETOLOGICA [10.1007/s00592-014-0576-0].";s:4:"data";s:10:"2014-03-12";s:2:"id";s:20:"PUBBLICAZIONE_184504";s:6:"handle";s:10:"2108/89628";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:140:"High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects";s:9:"metadata6";s:87:"Sesti, G; Andreozzi, F; Fiorentino, T; Mannino, G; Sciacqua, A; Marini, M; Perticone, F";s:9:"metadata7";s:25:"10.1007/s00592-014-0576-0";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:19;a:14:{s:9:"citazione";s:268:"Marini, M.A., Frontoni, S., Succurro, E., Arturi, F., Sciacqua, A., Hribal, M., et al. (2014). Insulin sensitivity, and β-cell function in relation to hemoglobin A1C. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 24(1), 27-33 [10.1016/j.numecd.2013.01.011].";s:4:"data";s:7:"2014-01";s:2:"id";s:20:"PUBBLICAZIONE_184510";s:6:"handle";s:10:"2108/89850";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:71:"Insulin sensitivity, and β-cell function in relation to hemoglobin A1C";s:9:"metadata6";s:95:"Marini, MA; Frontoni, S; Succurro, E; Arturi, F; Sciacqua, A; Hribal, M; Perticone, F; Sesti, G";s:9:"metadata7";s:28:"10.1016/j.numecd.2013.01.011";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:20;a:14:{s:9:"citazione";s:286:"Sesti, G., Mannino, G., Andreozzi, F., Greco, A., Perticone, M., Sciacqua, A., et al. (2014). A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. ATHEROSCLEROSIS, 232(1), 25-30 [10.1016/j.atherosclerosis.2013.10.024].";s:4:"data";s:7:"2014-01";s:2:"id";s:20:"PUBBLICAZIONE_184506";s:6:"handle";s:10:"2108/89848";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:119:"A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation";s:9:"metadata6";s:96:"Sesti, G; Mannino, G; Andreozzi, F; Greco, A; Perticone, M; Sciacqua, A; Marini, M; Perticone, F";s:9:"metadata7";s:37:"10.1016/j.atherosclerosis.2013.10.024";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:21;a:14:{s:9:"citazione";s:246:"Marini, M., Frontoni, S., Succurro, E., Arturi, F., Fiorentino, T., Sciacqua, A., et al. (2013). Insulin clearance is associated with carotid artery intima-media thickness. ATHEROSCLEROSIS, 229(2), 453-458 [10.1016/j.atherosclerosis.2013.06.011].";s:4:"data";s:7:"2013-08";s:2:"id";s:20:"PUBBLICAZIONE_184512";s:6:"handle";s:10:"2108/90093";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:74:"Insulin clearance is associated with carotid artery intima-media thickness";s:9:"metadata6";s:109:"Marini, M; Frontoni, S; Succurro, E; Arturi, F; Fiorentino, T; Sciacqua, A; Hribal, M; Perticone, F; Sesti, G";s:9:"metadata7";s:37:"10.1016/j.atherosclerosis.2013.06.011";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:22;a:14:{s:9:"citazione";s:278:"Mannino, G., Greco, A., De Lorenzo, C., Andreozzi, F., Marini, M., Perticone, F., et al. (2013). A fasting insulin-raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity. PLOS ONE, 8(12), e85483-e85483 [10.1371/journal.pone.0085483].";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_184503";s:6:"handle";s:10:"2108/90095";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:117:"A fasting insulin-raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity";s:9:"metadata6";s:84:"Mannino, G; Greco, A; De Lorenzo, C; Andreozzi, F; Marini, M; Perticone, F; Sesti, G";s:9:"metadata7";s:28:"10.1371/journal.pone.0085483";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:23;a:14:{s:9:"citazione";s:253:"Marini, M., Frontoni, S., Succurro, E., Arturi, F., Fiorentino, T., Sciacqua, A., et al. (2013). Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels. PLOS ONE, 8(10), e77440-e77440 [10.1371/journal.pone.0077440].";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_184508";s:6:"handle";s:10:"2108/90094";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:92:"Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels";s:9:"metadata6";s:109:"Marini, M; Frontoni, S; Succurro, E; Arturi, F; Fiorentino, T; Sciacqua, A; Hribal, M; Perticone, F; Sesti, G";s:9:"metadata7";s:28:"10.1371/journal.pone.0077440";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:24;a:14:{s:9:"citazione";s:211:"Sciacqua, A., Marini, M., Hribal, M., Perticone, F., & Sesti, G. (2013). Association of insulin resistance indexes to carotid intima-media thickness. PLOS ONE, 8(1), e53968-e53968 [10.1371/journal.pone.0053968].";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_184502";s:6:"handle";s:10:"2108/90096";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:75:"Association of insulin resistance indexes to carotid intima-media thickness";s:9:"metadata6";s:57:"Sciacqua, A; Marini, M; Hribal, M; Perticone, F; Sesti, G";s:9:"metadata7";s:28:"10.1371/journal.pone.0053968";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:25;a:14:{s:9:"citazione";s:320:"Marini, M.A., Succurro, E., Castaldo, E., Cufone, S., Arturi, F., Sciacqua, A., et al. (2012). Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. DIABETES CARE, 35(5), 1144-1149 [10.2337/dc11-2032].";s:4:"data";s:7:"2012-05";s:2:"id";s:20:"PUBBLICAZIONE_161975";s:6:"handle";s:10:"2108/77988";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:171:"Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria";s:9:"metadata6";s:117:"Marini, MA; Succurro, E; Castaldo, E; Cufone, S; Arturi, F; Sciacqua, A; Lauro, R; Hribal, ML; Perticone, F; Sesti, G";s:9:"metadata7";s:17:"10.2337/dc11-2032";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:26;a:14:{s:9:"citazione";s:277:"Marini, M.A., Succurro, E., Frontoni, S., Mastroianni, S., Arturi, F., Sciacqua, A., et al. (2012). Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. DIABETES CARE, 35(4), 868-872 [10.2337/dc11-2181].";s:4:"data";s:7:"2012-04";s:2:"id";s:20:"PUBBLICAZIONE_161924";s:6:"handle";s:10:"2108/77974";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:125:"Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels";s:9:"metadata6";s:122:"Marini, MA; Succurro, E; Frontoni, S; Mastroianni, S; Arturi, F; Sciacqua, A; Lauro, R; Hribal, ML; Perticone, F; Sesti, G";s:9:"metadata7";s:17:"10.2337/dc11-2181";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:27;a:14:{s:9:"citazione";s:313:"Cardellini, M., Menghini, R., Luzi, A., Davato, F., Cardolini, I., D'Alfonso, R., et al. (2011). Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness. DIABETES, 60(12), 3265-3270 [10.2337/db11-0162].";s:4:"data";s:7:"2011-12";s:2:"id";s:19:"PUBBLICAZIONE_89414";s:6:"handle";s:10:"2108/53469";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/12";s:9:"metadata4";N;s:9:"metadata5";s:166:"Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness";s:9:"metadata6";s:169:"Cardellini, M; Menghini, R; Luzi, A; Davato, F; Cardolini, I; D'Alfonso, R; Gentileschi, P; Rizza, S; Marini, MA; Porzio, O; Lauro, D; Sbraccia, P; Lauro, R; Federici, M";s:9:"metadata7";s:17:"10.2337/db11-0162";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:28;a:14:{s:9:"citazione";s:292:"Morviducci, L., Di Flaviani, A., Lauria, A., Pitocco, D., Pozzilli, P., Suraci, C., et al. (2011). Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit. DIABETES TECHNOLOGY & THERAPEUTICS, 13(10), 1071-1074 [10.1089/dia.2011.0056].";s:4:"data";s:7:"2011-10";s:2:"id";s:19:"PUBBLICAZIONE_89897";s:6:"handle";s:10:"2108/41435";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:113:"Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit";s:9:"metadata6";s:548:"Morviducci, L; Di Flaviani, A; Lauria, A; Pitocco, D; Pozzilli, P; Suraci, C; Frontoni, S; CSII Study Group Of Lazio Region, Italy. Collaborators: Cappa, M; Patera, IP; Manfrini, S; Bracaglia, D; Ciampittiello, G; Cicconetti, E; Ventura, C; Bloise, D; Tatti, P; Leotta, S; Visalli, N; Caputo, S; Ghirlanda, G; Giaccari, A; Cavallo, GM; Leonetti, F; Lauro, D; Mancabitti, ML; Marini, MA; Spallone, V; Napoli, A; Pugliese, G; Nardone, MR; Tubili, C; Giuliano, M; Fava, D; Piergiovanni, F; Forte, E; Tuccinardi, F; Chiaramonte, F; Buzzetti, R; Leto, G";s:9:"metadata7";s:21:"10.1089/dia.2011.0056";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:29;a:14:{s:9:"citazione";s:320:"Succurro, E., Marini, M.A., Arturi, F., Grembiale, A., Fiorentino, T.V., Andreozzi, F., et al. (2011). Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects. THE AMERICAN JOURNAL OF CARDIOLOGY, 107(11), 1650-5-1655 [10.1016/j.amjcard.2011.01.055].";s:4:"data";s:10:"2011-06-01";s:2:"id";s:19:"PUBBLICAZIONE_60517";s:6:"handle";s:10:"2108/53382";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:126:"Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects";s:9:"metadata6";s:137:"Succurro, E; Marini, MA; Arturi, F; Grembiale, A; Fiorentino, TV; Andreozzi, F; Sciacqua, A; Lauro, R; Hribal, ML; Perticone, F; Sesti, G";s:9:"metadata7";s:29:"10.1016/j.amjcard.2011.01.055";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:30;a:14:{s:9:"citazione";s:246:"Fiore, A., Marinoni, G.M., Piccione, A., Marini, M.A., D'Adamo, M., Lauro, R., et al. (2011). A rare cardiac finding in a morbidly obese patient with severe hypertension. INTERNAL AND EMERGENCY MEDICINE, 6(3), 241-244 [10.1007/s11739-010-0472-8].";s:4:"data";s:7:"2011-06";s:2:"id";s:19:"PUBBLICAZIONE_30601";s:6:"handle";s:10:"2108/24879";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/49 - Scienze Tecniche Dietetiche Applicate";s:9:"metadata4";N;s:9:"metadata5";s:75:"A rare cardiac finding in a morbidly obese patient with severe hypertension";s:9:"metadata6";s:84:"Fiore, AMV; Marinoni, GM; Piccione, A; Marini, MA; D'Adamo, M; Lauro, R; Sbraccia, P";s:9:"metadata7";s:25:"10.1007/s11739-010-0472-8";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:31;a:14:{s:9:"citazione";s:300:"Hribal, M., Presta, I., Procopio, T., Marini, M., Stančáková, A., Kuusisto, J., et al. (2011). Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B. DIABETOLOGIA, 54(4), 795-802 [10.1007/s00125-010-2038-8].";s:4:"data";s:7:"2011-04";s:2:"id";s:19:"PUBBLICAZIONE_60449";s:6:"handle";s:10:"2108/53392";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:140:"Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B";s:9:"metadata6";s:234:"Hribal, M; Presta, I; Procopio, T; Marini, M; Stančáková, A; Kuusisto, J; Andreozzi, F; Hammarstedt, A; Jansson, P; Grarup, N; Hansen, T; Walker, M; Stefan, N; Fritsche, A; Häring, H; Pedersen, O; Smith, U; Laakso, M; Sesti, G";s:9:"metadata7";s:25:"10.1007/s00125-010-2038-8";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:32;a:14:{s:9:"citazione";s:281:"Castaldo, E., Sabato, D., Lauro, D., Sesti, G., & Marini, M. (2011). Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance. PLOS ONE, 6(12), e28312-e28312 [10.1371/journal.pone.0028312].";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_89895";s:6:"handle";s:10:"2108/53650";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:148:"Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance";s:9:"metadata6";s:53:"Castaldo, E; Sabato, D; Lauro, D; Sesti, G; Marini, M";s:9:"metadata7";s:28:"10.1371/journal.pone.0028312";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:33;a:14:{s:9:"citazione";s:353:"Succurro, E., Andreozzi, F., Marini, M.A., Lauro, R., Hribal, M.L., Perticone, F., et al. (2009). Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 19(10), 713-719 [10.1016/j.numecd.2008.12.011].";s:4:"data";s:7:"2009-12";s:2:"id";s:19:"PUBBLICAZIONE_60524";s:6:"handle";s:10:"2108/41921";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:150:"Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects";s:9:"metadata6";s:83:"Succurro, E; Andreozzi, F; Marini, MA; Lauro, R; Hribal, ML; Perticone, F; Sesti, G";s:9:"metadata7";s:28:"10.1016/j.numecd.2008.12.011";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:34;a:14:{s:9:"citazione";s:306:"Succurro, E., Marini, M.A., Arturi, F., Grembiale, A., Lugarà, M., Andreozzi, F., et al. (2009). Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. ATHEROSCLEROSIS, 207(1), 245-249 [10.1016/j.atherosclerosis.2009.04.006].";s:4:"data";s:7:"2009-11";s:2:"id";s:19:"PUBBLICAZIONE_60503";s:6:"handle";s:10:"2108/41941";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:133:"Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis";s:9:"metadata6";s:133:"Succurro, E; Marini, MA; Arturi, F; Grembiale, A; Lugarà, M; Andreozzi, F; Sciacqua, A; Lauro, R; Hribal, ML; Perticone, F; Sesti, G";s:9:"metadata7";s:37:"10.1016/j.atherosclerosis.2009.04.006";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:35;a:14:{s:9:"citazione";s:240:"Presta, I., Andreozzi, F., Succurro, E., Marini, M.A., Laratta, E., Lauro, R., et al. (2009). IL-18 gene polymorphism and metabolic syndrome. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 19(2), 5-6 [10.1016/j.numecd.2008.10.002].";s:4:"data";s:7:"2009-02";s:2:"id";s:19:"PUBBLICAZIONE_60522";s:6:"handle";s:10:"2108/41927";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:46:"IL-18 gene polymorphism and metabolic syndrome";s:9:"metadata6";s:106:"Presta, I; Andreozzi, F; Succurro, E; Marini, MA; Laratta, E; Lauro, R; Hribal, ML; Perticone, F; Sesti, G";s:9:"metadata7";s:28:"10.1016/j.numecd.2008.10.002";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:36;a:14:{s:9:"citazione";s:300:"Succurro, E., Marini, M.A., Grembiale, A., Lugara, M., Andreozzi, F., Sciacqua, A., et al. (2009). Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. DIABETES/METABOLISM RESEARCH AND REVIEWS, 25(4), 351-356 [10.1002/dmrr.951].";s:4:"data";s:4:"2009";s:2:"id";s:18:"PUBBLICAZIONE_9090";s:6:"handle";s:10:"2108/40979";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:123:"Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels";s:9:"metadata6";s:121:"Succurro, E; Marini, MA; Grembiale, A; Lugara, M; Andreozzi, F; Sciacqua, A; Hribal, ML; Lauro, R; Perticone, F; Sesti, G";s:9:"metadata7";s:16:"10.1002/dmrr.951";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:37;a:14:{s:9:"citazione";s:288:"Marini, A., Spoletini, I., Rubino, I., Ciuffa, M., Bria, P., Martinotti, G., et al. (2008). The language of schizophrenia: an analysis of micro and macrolinguistic abilities and their neuropsychological correlates. SCHIZOPHRENIA RESEARCH, 105(1-3), 144-155 [10.1016/j.schres.2008.07.011].";s:4:"data";s:7:"2008-10";s:2:"id";s:20:"PUBBLICAZIONE_111800";s:6:"handle";s:10:"2108/56960";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:28:"Settore MED/25 - Psichiatria";s:9:"metadata4";N;s:9:"metadata5";s:121:"The language of schizophrenia: an analysis of micro and macrolinguistic abilities and their neuropsychological correlates";s:9:"metadata6";s:149:"Marini, A; Spoletini, I; Rubino, I; Ciuffa, M; Bria, P; Martinotti, G; Banfi, G; Boccascino, R; Strom, P; Siracusano, A; Caltagirone, C; Spalletta, G";s:9:"metadata7";s:28:"10.1016/j.schres.2008.07.011";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:38;a:14:{s:9:"citazione";s:259:"Succurro, E., Marini, M.A., Frontoni, S., Hribal, M.L., Andreozzi, F., Lauro, R., et al. (2008). Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. OBESITY, 16(8), 1881-1886 [10.1038/oby.2008.308].";s:4:"data";s:7:"2008-08";s:2:"id";s:19:"PUBBLICAZIONE_60500";s:6:"handle";s:10:"2108/41887";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:111:"Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals";s:9:"metadata6";s:96:"Succurro, E; Marini, MA; Frontoni, S; Hribal, ML; Andreozzi, F; Lauro, R; Perticone, F; Sesti, G";s:9:"metadata7";s:20:"10.1038/oby.2008.308";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:39;a:14:{s:9:"citazione";s:313:"Sesti, G., Andreozzi, F., Bonadonna, R.C., De Mattia, G., Leonetti, F., Luzi, L., et al. (2008). Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance: the GISIR database. DIABETES/METABOLISM RESEARCH AND REVIEWS, 24(2), 130-136 [10.1002/dmrr.775].";s:4:"data";s:7:"2008-02";s:2:"id";s:19:"PUBBLICAZIONE_60498";s:6:"handle";s:10:"2108/43740";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:138:"Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance: the GISIR database";s:9:"metadata6";s:118:"Sesti, G; Andreozzi, F; Bonadonna, RC; De Mattia, G; Leonetti, F; Luzi, L; Marini, MA; Natali, A; Vettor, R; Bonora, E";s:9:"metadata7";s:16:"10.1002/dmrr.775";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:40;a:14:{s:9:"citazione";s:317:"Staiger, H., Stancáková, A., Zilinskaite, J., Vänttinen, M., Hansen, T., Marini, M.A., et al. (2008). A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study. DIABETES, 57(2), 514-517 [10.2337/db07-1254].";s:4:"data";s:7:"2008-02";s:2:"id";s:19:"PUBBLICAZIONE_60489";s:6:"handle";s:10:"2108/43750";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:165:"A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study";s:9:"metadata6";s:189:"Staiger, H; Stancáková, A; Zilinskaite, J; Vänttinen, M; Hansen, T; Marini, MA; Hammarstedt, A; Jansson, P; Sesti, G; Smith, U; Pedersen, O; Laakso, M; Stefan, N; Fritsche, A; Häring, H";s:9:"metadata7";s:17:"10.2337/db07-1254";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:41;a:14:{s:9:"citazione";s:333:"Bonora, E., Capaldo, B., Perin, P.C., Del Prato, S., De Mattia, G., Frittitta, L., et al. (2008). Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects: the GISIR database. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 18(9), 624-631.";s:4:"data";s:4:"2008";s:2:"id";s:19:"PUBBLICAZIONE_13992";s:6:"handle";s:10:"2108/38484";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:162:"Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects: the GISIR database";s:9:"metadata6";s:219:"Bonora, E; Capaldo, B; Perin, PC; Del Prato, S; De Mattia, G; Frittitta, L; Frontoni, S; Leonetti, F; Luzi, L; Marchesini, G; Marini, MA; Natali, A; Paolisso, G; Piatti, PM; Pujia, A; Solini, A; Vettor, R; Bonadonna, RC";s:9:"metadata7";s:28:"10.1016/j.numecd.2007.05.002";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:42;a:14:{s:9:"citazione";s:188:"Succurro E., M.M. (2008). Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. OBESITY, 16(8), 1881-1886 [10.1038/oby.2008.308].";s:4:"data";s:4:"2008";s:2:"id";s:19:"PUBBLICAZIONE_21292";s:6:"handle";s:10:"2108/38485";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:111:"Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals";s:9:"metadata6";s:98:"Succurro E., Marini M.A., Frontoni S., Hribal M.L., Andreozzi F., Lauro R., Perticone F., Sesti G.";s:9:"metadata7";s:20:"10.1038/oby.2008.308";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:43;a:14:{s:9:"citazione";s:298:"Marini, M., Succurro, E., Frontoni, S., Hribal, M., Andreozzi, F., Lauro, R., et al. (2007). Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. DIABETES CARE, 30(8), 2145-2147 [10.2337/dc07-0419].";s:4:"data";s:7:"2007-08";s:2:"id";s:19:"PUBBLICAZIONE_60441";s:6:"handle";s:10:"2108/41880";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:151:"Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women";s:9:"metadata6";s:94:"Marini, M; Succurro, E; Frontoni, S; Hribal, M; Andreozzi, F; Lauro, R; Perticone, F; Sesti, G";s:9:"metadata7";s:17:"10.2337/dc07-0419";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:44;a:14:{s:9:"citazione";s:267:"Ludovico, O., Pellegrini, F., Di Paola, R., Minenna, A., Mastroianno, S., Cardellini, M., et al. (2007). Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk. OBESITY, 15(5), 1076-1081 [10.1038/oby.2007.617].";s:4:"data";s:7:"2007-05";s:2:"id";s:19:"PUBBLICAZIONE_60515";s:6:"handle";s:10:"2108/41362";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:111:"Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk";s:9:"metadata6";s:145:"Ludovico, O; Pellegrini, F; Di Paola, R; Minenna, A; Mastroianno, S; Cardellini, M; Marini, MA; Andreozzi, F; Vaccaro, O; Sesti, G; Trischitta, V";s:9:"metadata7";s:20:"10.1038/oby.2007.617";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:45;a:14:{s:9:"citazione";s:342:"Cardellini, M., Andreozzi, F., Laratta, E., Marini, M.A., Lauro, R., Hribal, M.L., et al. (2007). Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. DIABETES/METABOLISM RESEARCH AND REVIEWS, 23(2), 141-145 [10.1002/dmrr.679].";s:4:"data";s:7:"2007-02";s:2:"id";s:19:"PUBBLICAZIONE_60473";s:6:"handle";s:10:"2108/41367";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:166:"Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians";s:9:"metadata6";s:97:"Cardellini, M; Andreozzi, F; Laratta, E; Marini, MA; Lauro, R; Hribal, ML; Perticone, F; Sesti, G";s:9:"metadata7";s:16:"10.1002/dmrr.679";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:46;a:14:{s:9:"citazione";s:366:"Cardellini, M., Marini, M., Frontoni, S., Hribal, M., Andreozzi, F., Perticone, F., et al. (2007). Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM, 292(1), E347-E352 [10.1152/ajpendo.00291.2006].";s:4:"data";s:7:"2007-01";s:2:"id";s:19:"PUBBLICAZIONE_89944";s:6:"handle";s:10:"2108/41873";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:156:"Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients";s:9:"metadata6";s:109:"Cardellini, M; Marini, M; Frontoni, S; Hribal, M; Andreozzi, F; Perticone, F; Federici, M; Lauro, D; Sesti, G";s:9:"metadata7";s:26:"10.1152/ajpendo.00291.2006";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:47;a:14:{s:9:"citazione";s:342:"Cardellini, M., Andreozzi, F., Laratta, E., Marini, M.A., Lauro, R., Hribal, M.L., et al. (2007). Plasma interteukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. DIABETES/METABOLISM RESEARCH AND REVIEWS, 23(2), 141-145 [10.1002/dmrr.679].";s:4:"data";s:4:"2007";s:2:"id";s:19:"PUBBLICAZIONE_10214";s:6:"handle";s:10:"2108/40994";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:166:"Plasma interteukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians";s:9:"metadata6";s:97:"Cardellini, M; Andreozzi, F; Laratta, E; Marini, MA; Lauro, R; Hribal, ML; Petricone, F; Sesti, G";s:9:"metadata7";s:16:"10.1002/dmrr.679";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:48;a:14:{s:9:"citazione";s:300:"Scarpelli, D., Cardellini, M., Andreozzi, F., Laratta, E., Hribal, M.L., Marini, M.A., et al. (2006). Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. DIABETES, 55(5), 1529-1533 [10.2337/db06-0047].";s:4:"data";s:7:"2006-05";s:2:"id";s:19:"PUBBLICAZIONE_60523";s:6:"handle";s:10:"2108/40423";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:149:"Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects";s:9:"metadata6";s:121:"Scarpelli, D; Cardellini, M; Andreozzi, F; Laratta, E; Hribal, ML; Marini, MA; Tassi, V; Lauro, R; Perticone, F; Sesti, G";s:9:"metadata7";s:17:"10.2337/db06-0047";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:49;a:14:{s:9:"citazione";s:379:"Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432 [10.1161/01.ATV.0000196552.84475.fc].";s:4:"data";s:7:"2006-02";s:2:"id";s:19:"PUBBLICAZIONE_89412";s:6:"handle";s:10:"2108/40467";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:180:"Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase";s:9:"metadata6";s:126:"Rizza, S; Tesauro, M; Cardellini, M; Menghini, R; Bellia, A; Marini, M; Lauro, D; Sbraccia, P; Sesti, G; Lauro, R; Federici, M";s:9:"metadata7";s:34:"10.1161/01.ATV.0000196552.84475.fc";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:50;a:14:{s:9:"citazione";s:344:"Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M.A., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432.";s:4:"data";s:7:"2006-02";s:2:"id";s:19:"PUBBLICAZIONE_94481";s:6:"handle";s:10:"2108/41005";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:180:"Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase";s:9:"metadata6";s:127:"Rizza, S; Tesauro, M; Cardellini, M; Menghini, R; Bellia, A; Marini, MA; Lauro, D; Sbraccia, P; Sesti, G; Lauro, R; Federici, M";s:9:"metadata7";s:34:"10.1161/01.ATV.0000196552.84475.fc";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:51;a:14:{s:9:"citazione";s:280:"Andreozzi, F., Laratta, E., Cardellini, M., Marini, M.A., Lauro, R., Hribal, M.L., et al. (2006). Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. DIABETES, 55(7), 2021-2024 [10.2337/db06-0063].";s:4:"data";s:4:"2006";s:2:"id";s:18:"PUBBLICAZIONE_2954";s:6:"handle";s:10:"2108/41015";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:133:"Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects";s:9:"metadata6";s:97:"Andreozzi, F; Laratta, E; Cardellini, M; Marini, MA; Lauro, R; Hribal, ML; Perticone, F; Sesti, G";s:9:"metadata7";s:17:"10.2337/db06-0063";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:52;a:14:{s:9:"citazione";s:381:"Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M.A., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432 [10.1161/01.ATV.0000196552.84475.fc].";s:4:"data";s:4:"2006";s:2:"id";s:20:"PUBBLICAZIONE_239704";s:6:"handle";s:11:"2108/120837";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:180:"Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase";s:9:"metadata6";s:127:"Rizza, S; Tesauro, M; Cardellini, M; Menghini, R; Bellia, A; Marini, MA; Lauro, D; Sbraccia, P; Sesti, G; Lauro, R; Federici, M";s:9:"metadata7";s:34:"10.1161/01.ATV.0000196552.84475.fc";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:53;a:14:{s:9:"citazione";s:227:"Cardellini, M., Perego, L., D'Adamo, M., Marini, M., Procopio, C., Hribal, M., et al. (2005). C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. DIABETES CARE, 28(8), 2007-2012.";s:4:"data";s:7:"2005-08";s:2:"id";s:19:"PUBBLICAZIONE_60469";s:6:"handle";s:10:"2108/39908";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:99:"C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance";s:9:"metadata6";s:171:"Cardellini, M; Perego, L; D'Adamo, M; Marini, M; Procopio, C; Hribal, M; Andreozzi, F; Frontoni, S; Giacomelli, M; Paganelli, M; Pontiroli, A; Lauro, R; Folli, F; Sesti, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:54;a:14:{s:9:"citazione";s:259:"Cardellini, M., Perego, L., D'Adamo, M., Marini, M.A., Procopio, C., Hribal, M.L., et al. (2005). C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. DIABETES CARE, 28(8), 2007-2012 [10.2337/diacare.28.8.2007].";s:4:"data";s:7:"2005-08";s:2:"id";s:19:"PUBBLICAZIONE_30784";s:6:"handle";s:10:"2108/39938";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:99:"C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance";s:9:"metadata6";s:174:"Cardellini, M; Perego, L; D'Adamo, M; Marini, MA; Procopio, C; Hribal, ML; Andreozzi, F; Frontoni, S; Giacomelli, M; Paganelli, M; Pontiroli, AE; Lauro, R; Folli, F; Sesti, G";s:9:"metadata7";s:25:"10.2337/diacare.28.8.2007";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:55;a:14:{s:9:"citazione";s:275:"Mariani, L.M., Fusco, A., Turriziani, M., Veneziani, A., Marini, M.A., de Lorenzo, A., et al. (2005). Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity. HORMONE AND METABOLIC RESEARCH, 37(4), 242-245 [10.1055/s-2005-861410].";s:4:"data";s:7:"2005-04";s:2:"id";s:19:"PUBBLICAZIONE_60530";s:6:"handle";s:10:"2108/38306";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:100:"Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity";s:9:"metadata6";s:89:"Mariani, LM; Fusco, A; Turriziani, M; Veneziani, A; Marini, MA; de Lorenzo, A; Bertoli, A";s:9:"metadata7";s:21:"10.1055/s-2005-861410";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:56;a:14:{s:9:"citazione";s:288:"Sesti, G., Sciacqua, A., Cardellini, M., Marini, M., Maio, R., Vatrano, M., et al. (2005). Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. DIABETES CARE, 28(1), 120-125 [10.2337/diacare.28.1.120].";s:4:"data";s:7:"2005-01";s:2:"id";s:19:"PUBBLICAZIONE_88786";s:6:"handle";s:10:"2108/39940";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:138:"Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance";s:9:"metadata6";s:118:"Sesti, G; Sciacqua, A; Cardellini, M; Marini, M; Maio, R; Vatrano, M; Succurro, E; Lauro, R; Federici, M; Perticone, F";s:9:"metadata7";s:24:"10.2337/diacare.28.1.120";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:57;a:14:{s:9:"citazione";s:308:"D'Adamo, M., Perego, L., Cardellini, M., Marini, M.A., Frontoni, S., Andreozzi, F., et al. (2004). The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. DIABETES, 53(7), 1905-1910 [10.2337/diabetes.53.7.1905].";s:4:"data";s:7:"2004-07";s:2:"id";s:19:"PUBBLICAZIONE_30794";s:6:"handle";s:10:"2108/33957";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:151:"The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes";s:9:"metadata6";s:197:"D'Adamo, M; Perego, L; Cardellini, M; Marini, MA; Frontoni, S; Andreozzi, F; Sciacqua, A; Lauro, D; Sbraccia, P; Federici, M; Paganelli, M; Pontiroli, AE; Lauro, R; Perticone, F; Folli, F; Sesti, G";s:9:"metadata7";s:26:"10.2337/diabetes.53.7.1905";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:58;a:14:{s:9:"citazione";s:290:"Sesti, G., Marini, M.A., Cardellini, M., Sciacqua, A., Frontoni, S., Andreozzi, F., et al. (2004). The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. DIABETES CARE, 27(6), 1394-1398.";s:4:"data";s:4:"2004";s:2:"id";s:18:"PUBBLICAZIONE_4241";s:6:"handle";s:10:"2108/30969";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:157:"The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes";s:9:"metadata6";s:143:"Sesti, G; Marini, MA; Cardellini, M; Sciacqua, A; Frontoni, S; Andreozzi, F; Irace, C; Lauro, D; Gnasso, A; Federici, M; Perticone, F; Lauro, R";s:9:"metadata7";s:25:"10.2337/diacare.27.6.1394";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:59;a:14:{s:9:"citazione";s:235:"Mariani, L.M., Marini, M.A., Veneziani, A., Bertoli, A., & Lauro, R. (2003). Morbid obesity: evaluation of metabolic indexes after adjustable silicone gastric banding. ACTA DIABETOLOGICA, 40 Suppl 1, S263-5 [10.1007/s00592-003-0082-2].";s:4:"data";s:7:"2003-10";s:2:"id";s:19:"PUBBLICAZIONE_60474";s:6:"handle";s:10:"2108/53389";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:89:"Morbid obesity: evaluation of metabolic indexes after adjustable silicone gastric banding";s:9:"metadata6";s:59:"Mariani, LM; Marini, MA; Veneziani, A; Bertoli, A; Lauro, R";s:9:"metadata7";s:25:"10.1007/s00592-003-0082-2";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:60;a:14:{s:9:"citazione";s:333:"Marini, M.A., Frontoni, S., Mineo, D., Bracaglia, D., Cardellini, M., De Nicolais, P., et al. (2003). The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 88(7), 3368-3371 [10.1210/jc.2002-021716].";s:4:"data";s:7:"2003-07";s:2:"id";s:19:"PUBBLICAZIONE_30823";s:6:"handle";s:10:"2108/35512";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:133:"The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients";s:9:"metadata6";s:172:"Marini, MA; Frontoni, S; Mineo, D; Bracaglia, D; Cardellini, M; De Nicolais, P; Baroni, A; D'Alfonso, R; Perna, M; Lauro, D; Federici, M; Gambardella, S; Lauro, R; Sesti, G";s:9:"metadata7";s:22:"10.1210/jc.2002-021716";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:61;a:14:{s:9:"citazione";s:279:"Sesti, G., Cardellini, M., Marini, M., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-1283 [10.2337/diabetes.52.5.1280].";s:4:"data";s:7:"2003-05";s:2:"id";s:19:"PUBBLICAZIONE_89942";s:6:"handle";s:10:"2108/53664";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:124:"A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects";s:9:"metadata6";s:180:"Sesti, G; Cardellini, M; Marini, M; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R";s:9:"metadata7";s:26:"10.2337/diabetes.52.5.1280";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:62;a:14:{s:9:"citazione";s:247:"Sesti, G., Cardellini, M., Marini, M., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-3.";s:4:"data";s:7:"2003-05";s:2:"id";s:19:"PUBBLICAZIONE_60445";s:6:"handle";s:10:"2108/53395";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:124:"A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects";s:9:"metadata6";s:180:"Sesti, G; Cardellini, M; Marini, M; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:63;a:14:{s:9:"citazione";s:252:"Sesti, G., Cardellini, M., Marini, M.A., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-1283.";s:4:"data";s:7:"2003-05";s:2:"id";s:19:"PUBBLICAZIONE_30787";s:6:"handle";s:10:"2108/53201";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:124:"A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects";s:9:"metadata6";s:181:"Sesti, G; Cardellini, M; Marini, MA; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:64;a:14:{s:9:"citazione";s:271:"D'Alfonso, R., Marini, M., Frittitta, L., Sorge, R., Frontoni, S., Porzio, O., et al. (2003). Polymorphisms of the insulin receptor subtrate-2 in patients with type 2 diabetes. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 88(1), 317-322 [10.1210/jc.2002-020807].";s:4:"data";s:7:"2003-01";s:2:"id";s:17:"PUBBLICAZIONE_928";s:6:"handle";s:10:"2108/50473";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:81:"Polymorphisms of the insulin receptor subtrate-2 in patients with type 2 diabetes";s:9:"metadata6";s:157:"D'Alfonso, R; Marini, M; Frittitta, L; Sorge, R; Frontoni, S; Porzio, O; Mariani, L; Lauro, D; Gambardella, S; Trischitta, V; Federici, M; Lauro, R; Sesti, G";s:9:"metadata7";s:22:"10.1210/jc.2002-020807";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:65;a:14:{s:9:"citazione";s:248:"D'Alfonso, R., Marini, M.A., Frittitta, L., Sorge, R., Frontoni, S., Porzio, O., et al. (2003). Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 88(1), 317-22.";s:4:"data";s:7:"2003-01";s:2:"id";s:19:"PUBBLICAZIONE_60483";s:6:"handle";s:10:"2108/53387";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:82:"Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes";s:9:"metadata6";s:159:"D'Alfonso, R; Marini, MA; Frittitta, L; Sorge, R; Frontoni, S; Porzio, O; Mariani, LM; Lauro, D; Gambardella, S; Trischitta, V; Federici, M; Lauro, R; Sesti, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:66;a:14:{s:9:"citazione";s:249:"D'Alfonso, R., Marini, M.A., Frittitta, L., Sorge, R., Frontoni, S., Porzio, O., et al. (2003). Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 88(1), 317-322.";s:4:"data";s:7:"2003-01";s:2:"id";s:19:"PUBBLICAZIONE_30819";s:6:"handle";s:10:"2108/53445";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:82:"Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes";s:9:"metadata6";s:159:"D'Alfonso, R; Marini, MA; Frittitta, L; Sorge, R; Frontoni, S; Porzio, O; Mariani, LM; Lauro, D; Gambardella, S; Trischitta, V; Federici, M; Lauro, R; Sesti, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:67;a:14:{s:9:"citazione";s:218:"Mariani, L.M., Marini, M.A., Veneziani, A., Bertoli, A., & Lauro, R. (2003). Morbid obesity: evaluation of metabolic indexes after adjustable silicone gastric banding. In Acta Diabetologica [10.1007/s00592-003-0082-2].";s:4:"data";s:4:"2003";s:2:"id";s:19:"PUBBLICAZIONE_16313";s:6:"handle";s:10:"2108/53642";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:89:"Morbid obesity: evaluation of metabolic indexes after adjustable silicone gastric banding";s:9:"metadata6";s:59:"Mariani, LM; Marini, MA; Veneziani, A; Bertoli, A; Lauro, R";s:9:"metadata7";s:25:"10.1007/s00592-003-0082-2";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:68;a:14:{s:9:"citazione";s:187:"Sesti G., C.M. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES [10.2337/diabetes.52.5.1280].";s:4:"data";s:4:"2003";s:2:"id";s:19:"PUBBLICAZIONE_16150";s:6:"handle";s:10:"2108/50470";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/13 - Endocrinologia";s:9:"metadata4";N;s:9:"metadata5";s:124:"A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects";s:9:"metadata6";s:182:"Sesti G., Cardellini M., Marini M.A., Frontoni S., D'Adamo M., Del Guerra S., Lauro D., De Nicolais P., Sbraccia P., Del Prato S., Gambardella S., Federici M., Marchetti P., Lauro R.";s:9:"metadata7";s:26:"10.2337/diabetes.52.5.1280";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:69;a:14:{s:9:"citazione";s:205:"Bertoli, A., Magnaterra, R., Borboni, P., Marini, M.A., Barini, A., Fusco, A., et al. (1998). Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity. HORMONE RESEARCH, 49(1), 17-21.";s:4:"data";s:4:"1998";s:2:"id";s:19:"PUBBLICAZIONE_60480";s:6:"handle";s:10:"2108/53388";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:78:"Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity";s:9:"metadata6";s:82:"Bertoli, A; Magnaterra, R; Borboni, P; Marini, MA; Barini, A; Fusco, A; Bollea, MR";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:70;a:14:{s:9:"citazione";s:240:"Federici, M., Porzio, O., Zucaro, L., Giovannone, B., Borboni, P., Marini, M.A., et al. (1997). Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 135(1), 41-7.";s:4:"data";s:10:"1997-11-30";s:2:"id";s:19:"PUBBLICAZIONE_60525";s:6:"handle";s:10:"2108/53379";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:91:"Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients";s:9:"metadata6";s:92:"Federici, M; Porzio, O; Zucaro, L; Giovannone, B; Borboni, P; Marini, MA; Lauro, D; Sesti, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:71;a:14:{s:9:"citazione";s:242:"Federici, M., Porzio, O., Zucaro, L., Giovannone, B., Borboni, P., Marini, M.A., et al. (1997). Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue front NIDDM patients. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 135(1), 41-47.";s:4:"data";s:4:"1997";s:2:"id";s:19:"PUBBLICAZIONE_13613";s:6:"handle";s:10:"2108/53044";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:62:"Settore M-EDF/01 - Metodi e Didattiche delle Attivita' Motorie";s:9:"metadata4";N;s:9:"metadata5";s:92:"Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue front NIDDM patients";s:9:"metadata6";s:92:"Federici, M; Porzio, O; Zucaro, L; Giovannone, B; Borboni, P; Marini, MA; Lauro, D; Sesti, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:72;a:14:{s:9:"citazione";s:328:"Sesti, G., D'Alfonso, R., Vargas Punti, M., Tullio, A., Liu, Y., Federici, M., et al. (1996). Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects. DIABETOLOGIA, 39(3), 289-297.";s:4:"data";s:4:"1996";s:2:"id";s:18:"PUBBLICAZIONE_6322";s:6:"handle";s:10:"2108/53035";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:203:"Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects";s:9:"metadata6";s:114:"Sesti, G; D'Alfonso, R; Vargas Punti, M; Tullio, A; Liu, Y; Federici, M; Borboni, P; Marini, M; Lauro, R; Fusco, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:73;a:14:{s:9:"citazione";s:260:"Bertoli, A., Fusco, A., Magnani, A., Marini, M., Di Daniele, N., Gatti, S., et al. (1995). Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 103(1), 15-20 [10.1055/s-0029-1211324].";s:4:"data";s:4:"1995";s:2:"id";s:19:"PUBBLICAZIONE_60446";s:6:"handle";s:10:"2108/53394";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:76:"Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism";s:9:"metadata6";s:78:"Bertoli, A; Fusco, A; Magnani, A; Marini, M; Di Daniele, N; Gatti, S; Lauro, R";s:9:"metadata7";s:22:"10.1055/s-0029-1211324";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:74;a:14:{s:9:"citazione";s:237:"Bertoli, A., Fusco, A., Magnani, A., Marini, M.A., Di Daniele, N., Gatti, S., et al. (1995). Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 103(1), 15-20.";s:4:"data";s:4:"1995";s:2:"id";s:19:"PUBBLICAZIONE_17798";s:6:"handle";s:10:"2108/53290";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:76:"Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism";s:9:"metadata6";s:79:"Bertoli, A; Fusco, A; Magnani, A; Marini, MA; Di Daniele, N; Gatti, S; Lauro, R";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:75;a:14:{s:9:"citazione";s:231:"Sesti, G., Tullio, A., D'Alfonso, R., Napolitano, M., Marini, M., Borboni, P., et al. (1994). Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein. ACTA DIABETOLOGICA, 31(2), 59-65.";s:4:"data";s:7:"1994-06";s:2:"id";s:19:"PUBBLICAZIONE_60450";s:6:"handle";s:10:"2108/53391";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:102:"Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein";s:9:"metadata6";s:119:"Sesti, G; Tullio, A; D'Alfonso, R; Napolitano, M; Marini, M; Borboni, P; Longhi, R; Albonici, L; Fusco, A; Aglianò, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:76;a:14:{s:9:"citazione";s:233:"Sesti, G., Tullio, A., D'Alfonso, R., Napolitano, M., Marini, M.a., Borboni, P., et al. (1994). Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein. ACTA DIABETOLOGICA, 31(2), 59-65.";s:4:"data";s:7:"1994-06";s:2:"id";s:19:"PUBBLICAZIONE_52495";s:6:"handle";s:10:"2108/14902";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/04 - Patologia Generale";s:9:"metadata4";N;s:9:"metadata5";s:102:"Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein";s:9:"metadata6";s:125:"Sesti, G; Tullio, A; D'Alfonso, R; Napolitano, M; Marini, Ma; Borboni, P; Longhi, R; ALBONICI BOVE, L; Fusco, A; Aglianò, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:77;a:14:{s:9:"citazione";s:248:"Sesti, G., Tullio, A., Marini, M., Manera, E., Borboni, P., Accili, D., et al. (1994). Role of the exon 11 of the insulin receptor gene on insulin binding identified by anti-peptide antibodies. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 101(1-2), 121-7.";s:4:"data";s:7:"1994-05";s:2:"id";s:19:"PUBBLICAZIONE_60444";s:6:"handle";s:10:"2108/53396";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:105:"Role of the exon 11 of the insulin receptor gene on insulin binding identified by anti-peptide antibodies";s:9:"metadata6";s:110:"Sesti, G; Tullio, A; Marini, M; Manera, E; Borboni, P; Accili, D; Longhi, R; Fusco, A; Lauro, R; Montemurro, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:78;a:14:{s:9:"citazione";s:201:"Urbani, A., Bongiorno, L., Marini, M., Bolacchi, F., Zona, C., & Roda, L. (1994). Effect of differentiation on hydrolysis and association of Leu-enkephalin to K562(S) cells. PEPTIDES, 15(7), 1213-1222.";s:4:"data";s:4:"1994";s:2:"id";s:20:"PUBBLICAZIONE_134992";s:6:"handle";s:10:"2108/65207";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/09";s:9:"metadata4";N;s:9:"metadata5";s:90:"Effect of differentiation on hydrolysis and association of Leu-enkephalin to K562(S) cells";s:9:"metadata6";s:65:"Urbani, A; Bongiorno, L; Marini, M; Bolacchi, F; Zona, C; Roda, L";s:9:"metadata7";s:28:"10.1016/0196-9781(94)90144-9";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:79;a:14:{s:9:"citazione";s:199:"Urbani, A., Bongiorno, L., Marini, M., Zona, C., & Roda, L. (1994). Hydrolysis of leucine enkephalin and its association to the K562(S) erythroleukaemic cell line. IMMUNOPHARMACOLOGY, 27(2), 119-130.";s:4:"data";s:4:"1994";s:2:"id";s:20:"PUBBLICAZIONE_134987";s:6:"handle";s:10:"2108/65210";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/09";s:9:"metadata4";N;s:9:"metadata5";s:94:"Hydrolysis of leucine enkephalin and its association to the K562(S) erythroleukaemic cell line";s:9:"metadata6";s:52:"Urbani, A; Bongiorno, L; Marini, M; Zona, C; Roda, L";s:9:"metadata7";s:28:"10.1016/0162-3109(94)90046-9";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:80;a:14:{s:9:"citazione";s:270:"Sesti, G., Marini, M., Briata, P., Tullio, A., Montemurro, A., Borboni, P., et al. (1992). Androgens increase insulin receptor mRNA levels, insulin binding, and insulin responsiveness in HEp-2 larynx carcinoma cells. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 86(1-2), 111-8.";s:4:"data";s:7:"1992-07";s:2:"id";s:19:"PUBBLICAZIONE_60439";s:6:"handle";s:10:"2108/53397";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:124:"Androgens increase insulin receptor mRNA levels, insulin binding, and insulin responsiveness in HEp-2 larynx carcinoma cells";s:9:"metadata6";s:102:"Sesti, G; Marini, M; Briata, P; Tullio, A; Montemurro, A; Borboni, P; De Pirro, R; Gherzi, R; Lauro, R";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:81;a:14:{s:9:"citazione";s:235:"Sesti, G., Marini, M.A., Montemurro, A., Condorelli, L., Borboni, P., Haring, H.U., et al. (1992). Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. DIABETES, 41(1), 6-11.";s:4:"data";s:7:"1992-01";s:2:"id";s:19:"PUBBLICAZIONE_60497";s:6:"handle";s:10:"2108/53385";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:112:"Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct";s:9:"metadata6";s:123:"Sesti, G; Marini, MA; Montemurro, A; Condorelli, L; Borboni, P; Haring, HU; Ullrich, A; Goldfine, ID; De Pirro, R; Lauro, R";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:82;a:14:{s:9:"citazione";s:321:"Sesti, G., Marini, M.A., Tullio, A.N., Montemurro, A., Borboni, P., Fusco, A., et al. (1991). Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 181(3), 1419-24.";s:4:"data";s:10:"1991-12-31";s:2:"id";s:19:"PUBBLICAZIONE_60529";s:6:"handle";s:10:"2108/53377";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:156:"Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients";s:9:"metadata6";s:90:"Sesti, G; Marini, MA; Tullio, AN; Montemurro, A; Borboni, P; Fusco, A; Accili, D; Lauro, R";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:83;a:14:{s:9:"citazione";s:297:"Sesti, G., Marini, M., Montemurro, A., Borboni, P., Di Cola, G., Bertoli, A., et al. (1991). Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 14(11), 913-918.";s:4:"data";s:7:"1991-12";s:2:"id";s:20:"PUBBLICAZIONE_131871";s:6:"handle";s:10:"2108/65771";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:143:"Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies";s:9:"metadata6";s:93:"Sesti, G; Marini, M; Montemurro, A; Borboni, P; Di Cola, G; Bertoli, A; De Pirro, R; Lauro, R";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:84;a:14:{s:9:"citazione";s:257:"De Pirro, R., Borboni, P., Marini, M.A., Montemurro, A., Sesti, G., & Lauro, R. (1990). Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 13(11), 951-68.";s:4:"data";s:7:"1990-12";s:2:"id";s:19:"PUBBLICAZIONE_60495";s:6:"handle";s:10:"2108/53386";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:109:"Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action";s:9:"metadata6";s:70:"De Pirro, R; Borboni, P; Marini, MA; Montemurro, A; Sesti, G; Lauro, R";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:85;a:14:{s:9:"citazione";s:261:"Borboni, P., Di Cola, G., Sesti, G., Marini, M., Del Porto, P., Gilardini Montani, M., et al. (1989). Beta-endorphin receptors on cultured and freshly isolated lymphocytes from normal subjects. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 163(1), 642-8.";s:4:"data";s:10:"1989-08-30";s:2:"id";s:19:"PUBBLICAZIONE_60448";s:6:"handle";s:10:"2108/53393";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:90:"Beta-endorphin receptors on cultured and freshly isolated lymphocytes from normal subjects";s:9:"metadata6";s:102:"Borboni, P; Di Cola, G; Sesti, G; Marini, M; Del Porto, P; Gilardini Montani, M; Lauro, R; De Pirro, R";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:86;a:14:{s:9:"citazione";s:272:"Bertoli, A., Caputo, S., Marini, M.A., Santini, S.A., Ghirlanda, G., & Greco, A.V. (1989). Inhibition of basal insulin secretion induces insulin resistance in normal man: evidence for a tonic effect of insulin on carbohydrate metabolism. HORMONE RESEARCH, 31(5-6), 238-43.";s:4:"data";s:4:"1989";s:2:"id";s:19:"PUBBLICAZIONE_60520";s:6:"handle";s:10:"2108/53381";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:145:"Inhibition of basal insulin secretion induces insulin resistance in normal man: evidence for a tonic effect of insulin on carbohydrate metabolism";s:9:"metadata6";s:71:"Bertoli, A; Caputo, S; Marini, MA; Santini, SA; Ghirlanda, G; Greco, AV";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:87;a:14:{s:9:"citazione";s:228:"Caputo, S., Bertoli, A., Marini, M., Santini, G., Ghirlanda, G., & Greco, A. (1988). [Insulin secretion and insulin resistance in patients failing to respond to oral hypoglycemic agents]. MINERVA ENDOCRINOLOGICA, 13(3), 167-172.";s:4:"data";s:4:"1988";s:2:"id";s:20:"PUBBLICAZIONE_131875";s:6:"handle";s:10:"2108/65756";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:101:"[Insulin secretion and insulin resistance in patients failing to respond to oral hypoglycemic agents]";s:9:"metadata6";s:68:"Caputo, S; Bertoli, A; Marini, M; Santini, G; Ghirlanda, G; Greco, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:88;a:14:{s:9:"citazione";s:262:"Sesti, G., Marini, M., Montemurro, A., Di Daniele, N., Bertoli, A., Cordera, R., et al. (1988). [Preparation of 125I-labelled monoclonal antibodies of the insulin receptor]. COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 182(2), 167-76.";s:4:"data";s:4:"1988";s:2:"id";s:19:"PUBBLICAZIONE_60427";s:6:"handle";s:10:"2108/53398";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:76:"[Preparation of 125I-labelled monoclonal antibodies of the insulin receptor]";s:9:"metadata6";s:123:"Sesti, G; Marini, M; Montemurro, A; Di Daniele, N; Bertoli, A; Cordera, R; Andraghetti, G; De Pirro, R; Lauro, R; Monaco, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}}" } ["meta_keywords"]=> array(1) { [0]=> string(1) "," } ["reserved"]=> array(1) { [0]=> string(1) "0" } ["auth_ip"]=> array(1) { [0]=> string(1) "0" } } ["_fieldBoosts":protected]=> array(6) { ["content_id"]=> bool(false) ["content_title"]=> bool(false) ["description"]=> bool(false) ["meta_keywords"]=> bool(false) ["reserved"]=> bool(false) ["auth_ip"]=> bool(false) } } }